UZH-Logo

Maintenance Infos

Browse by Communities & Collections - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items at this level: 4143.

Aapro, M S

Audisio, C; Stahel, V; Aapro, M S; Costa, A; Pandey, M; Pavlidis, N (2008). Successful publishing: How to get your paper accepted. Surgical Oncology, 18(4):350-356.

Abaecherli, M

Opitz, I; Soltermann, A; Abaecherli, M; Hinterberger, M; Probst-Hensch, N; Stahel, R; Moch, H; Weder, W (2008). PTEN expression is a strong predictor of survival in mesothelioma patients. European Journal of Cardio-Thoracic Surgery, 33(3):502-506.

Abecasis, M

Meissner, J; Finel, H; Dietrich, S; Boumendil, A; Kanfer, E; Laboure, G; Abecasis, M; Cornelissen, J; Delage, J; Finke, J; Hess, U; Ludwig, H; Mohty, M; Pabst, T; Pioltelli, P; Robinson, S; Samaras, P; Montoto, S; Dreger, P (2017). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone Marrow Transplantation, 52(4):650-652.

Abera, A

von Minckwitz, G; Harder, S; Hövelmann, S; Jäger, E; Al-Batran, S E; Loibl, S G; Atmaca, A; Cimpoiasu, C; Neumann, A M; Abera, A; Knuth, A L; Kaufmann, M; Jäger, D; Maurer, A B; Wels, W S (2005). Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas. Breast Cancer Research, 7(5):R617-R626.

Abken, H

Stewart-Jones, G; Wadle, A; Hombach, A; Shenderov, E; Held, G; Fischer, E; Kleber, S; Stenner-Liewen, F; Bauer, S; McMichael, A; Knuth, A; Abken, H; Hombach, A A; Cerundolo, V; Jones, E Y; Renner, C (2009). Rational development of high-affinity T-cell receptor-like antibodies. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(14):5784-5788.

Absenger, G

Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A (2014). A functional germline variant in GLI1 implicates Hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clinical Cancer Research, 20(6):1687-1697.

Achermann, Rita

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri; Szucs, Thomas; Pestalozzi, Bernhard C; Schwenkglenks, Matthias (2015). Cancer-related therapies at the end of life in hospitalized cancer patients from four swiss cantons: SAKK 89/09. Oncology, 88(1):18-27.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons a retrospective database study (SAKK 89/09). BMC Cancer, 14:306.

Ackermann, M

Shi, Y; Hollenstein, A; Felley-Bosco, E; Fraefel, C; Ackermann, M; Soltermann, A; Weder, W; Stahel, R A; Pruschy, M; Opitz, I (2011). Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Lung Cancer, 71(3):370-371.

Acklin, Yves Pascal

Body, Jean-Jacques; Pereira, João; Sleeboom, Harm; Maniadakis, Nikos; Terpos, Evangelos; Acklin, Yves Pascal; Finek, Jindrich; Gunther, Oliver; Hechmati, Guy; Mossman, Tony; Costa, Luis; Rogowski, Wojciech; Nahi, Hareth; von Moos, Roger (2016). Health resource utilization associated with skeletal-related events: results from a retrospective European study. European Journal of Health Economics, 17(6):711-721.

Ademi, Z

Matter-Walstra, K; Braun, R; Kolb, C; Ademi, Z; Dummer, R; Pestalozzi, B C; Schwenkglenks, M (2015). A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting. British Journal of Dermatology, 173(6):1462-1470.

Adjei, A

Besse, B; Adjei, A; Baas, P; Meldgaard, P; Nicolson, M; Paz-Ares, L; Reck, M; Smit, E F; Syrigos, K; Stahel, R; Felip, E; Peters, S (2014). 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Annals of Oncology, 25(8):1475-1484.

Adjei, Alex A

Stahel, Rolf; Peters, Solange; Baas, Paul; Brambilla, Elisabeth; Cappuzzo, Federico; De Ruysscher, Dirk; Eberhardt, Wilfried Ernst Erich; Felip, Enriqueta; Fennell, Dean; Marchetti, Antonio; Paz-Ares, Luis; Adjei, Alex A (2013). Strategies for improving outcomes in NSCLC: a look to the future. Lung Cancer, 82(3):375-382.

Adrian, N

Bauer, S; Oosterwijk-Wakka, J C; Adrian, N; Oosterwijk, E; Fischer, E; Wüest, T; Stenner, F; Perani, A; Cohen, L S; Knuth, A; Divgi, C; Jäger, D; Scott, A M; Ritter, G; Old, L J; Renner, C (2009). Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg. International Journal of Cancer, 125(1):115-123.

Bauer, S; Adrian, N; Siebenborn, U; Fadle, N; Plesko, M; Fischer, E; Wüest, T; Stenner, F; Mertens, J C; Knuth, A; Ritter, G; Old, L J; Renner, C (2009). Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8. Cancer Immunity, 9(2):1-10.

Aebersold, Daniel M

Stahel, Rolf A; Riesterer, Oliver; Xyrafas, Alexandros; Opitz, Isabelle; Beyeler, Michael; Ochsenbein, Adrian; Früh, Martin; Cathomas, Richard; Nackaerts, Kristiaan; Peters, Solange; Mamot, Christoph; Zippelius, Alfred; Mordasini, Carlo; Caspar, Clemens B; Eckhardt, Katrin; Schmid, Ralph A; Aebersold, Daniel M; Gautschi, Oliver; Nagel, Wolfgang; Töpfer, Michael; Krayenbuehl, Jerome; Ribi, Karin; Ciernik, Llja F; Weder, Walter (2015). Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncology, 16(16):1651-1658.

Aebersold, Ruedi

Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasits, Ulrich; Gundry, Rebekah L; Yoon, Charles; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Härtlová, Anetta; Van Eyk, Jennifer E; Bourquin, Jean-Pierre; Aebersold, Ruedi; Boheler, Kenneth R; Zandstra, Peter; Wollscheid, Bernd (2015). A mass spectrometric-derived cell surface protein atlas. PLoS ONE, 10(3):e0121314.

Cerciello, Ferdinando; Choi, Meena; Nicastri, Annalisa; Bausch-Fluck, Damaris; Ziegler, Annemarie; Vitek, Olga; Felley-Bosco, Emanuela; Stahel, Rolf; Aebersold, Ruedi; Wollscheid, Bernd (2013). Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring. Clinical Proteomics, 10:16.

Surinova, Silvia; Schiess, Ralph; Hüttenhain, Ruth; Cerciello, Ferdinando; Wollscheid, Bernd; Aebersold, Ruedi (2011). On the development of plasma protein biomarkers. Journal of Proteome Research, 10(1):5-16.

Aebi, S

Pagani, O; Klingbiel, D; Ruhstaller, T; Nolè, F; Eppenberger, S; Oehlschlegel, C; Bernhard, J; Brauchli, P; Hess, D; Mamot, C; Munzone, E; Pestalozzi, B; Rabaglio, M; Aebi, S; Ribi, K; Rochlitz, C; Rothgiesser, K; Thürlimann, B; Moos, R von; Zaman, K; Goldhirsch, A; Swiss Group for Clinical Cancer Research (SAKK) (2017). Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized Phase III trial SAKK 22/99. Annals of Oncology, 28(2):305-312.

Strasser, F; Blum, D; von Moos, R; Cathomas, R; Ribi, K; Aebi, S; Betticher, D; Hayoz, S; Klingbiel, D; Brauchli, P; Haefner, M; Mauri, S; Kaasa, S; Koeberle, D (2016). The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Annals of Oncology, 27(2):324-332.

Aebi, Stefan

Hofer, Silvia; Mengele, Karin; Schmitt, Manfred; Pestalozzi, Bernhard; Aebi, Stefan (2015). Complement activation and rituximab distribution in CNS NHL: letter. Clinical Cancer Research, 21(2):490.

Aguzzi, Adriano

Kiessling, Michael K; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Lang, Silvia; Scharl, Michael; Aguzzi, Adriano; Oldrige, Derek A; Maris, John M; Rogler, Gerhard (2016). Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma. PLoS ONE, 11(1):e0147682.

Ahluwalia, Manmeet S

Kondziolka, Douglas; Parry, Phillip V; Lunsford, L Dade; Kano, Hideyuki; Flickinger, John C; Rakfal, Susan; Arai, Yoshio; Loeffler, Jay S; Rush, Stephen; Knisely, Jonathan P S; Sheehan, Jason; Friedman, William; Tarhini, Ahmad A; Francis, Lanie; Lieberman, Frank; Ahluwalia, Manmeet S; Linskey, Mark E; McDermott, Michael; Sperduto, Paul; Stupp, Roger (2014). The accuracy of predicting survival in individual patients with cancer. Journal of Neurosurgery, 120(1):24-30.

Aikawa, E

Brokopp, C E; Schoenauer, R; Richards, P; Bauer, S; Lohmann, C; Emmert, M Y; Weber, B; Winnik, S; Aikawa, E; Graves, K; Genoni, M; Vogt, P; Luscher, T F; Renner, C; Hoerstrup, S P; Matter, C M (2011). Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. European Heart Journal, 32(21):2713-2722.

Aix, Santiago Ponce

Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massutí, Bartomeu; Palmero, Ramon; Aix, Santiago Ponce; Carcereny, Enric; Früh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios; Cuffe, Sinead; Bidoli, Paolo; Favaretto, Adolfo; Froesch, Patrizia; Reguart, Noemí; Puente, Javier; Coate, Linda; Barlesi, Fabrice; Rauch, Daniel; Thomas, Michael; Camps, Carlos; Gómez-Codina, Jose; Majem, Margarita; Porta, Rut; Shah, Riyaz; Hanrahan, Emer; et al (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Lancet Respiratory Medicine, 5(5):435-444.

Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; Sanchez, Ramón Palmero; Villa Guzmán, José Carlos; Martin, Ricardo Collado; Peralta, Sergio; Insa, Amelia; Summers, Yvonne; Láng, István; Horgan, Anne; Ciardiello, Fortunato; de Hosson, Sander; et al (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of Thoracic Oncology, 12(4):752-762.

Al-Batran, S E

Atmaca, A; Al-Batran, S E; Neumann, A; Kolassa, Y; Jäger, D; Knuth, A; Jäger, E (2009). Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - A phase II study. Gynecologic oncology, 112(2):384-388.

Al-Batran, S E; Hartmann, J T; Probst, S; Schmalenberg, H; Hollerbach, S; Hofheinz, R; Rethwisch, V; Seipelt, G; Homann, N; Wilhelm, G; Schuch, G; Stoehlmacher, J; Derigs, H G; Hegewisch-Becker, S; Grossmann, J; Pauligk, C; Atmaca, A; Bokemeyer, C; Knuth, A; Jäger, E (2008). Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. Journal of Clinical Oncology, 26(9):1435-1442.

von Minckwitz, G; Harder, S; Hövelmann, S; Jäger, E; Al-Batran, S E; Loibl, S G; Atmaca, A; Cimpoiasu, C; Neumann, A M; Abera, A; Knuth, A L; Kaufmann, M; Jäger, D; Maurer, A B; Wels, W S (2005). Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas. Breast Cancer Research, 7(5):R617-R626.

Al-Mossawi, Mohammad Hussein

McHugh, Kirsty; Rysnik, Oliwia; Kollnberger, Simon; Shaw, Jacqueline; Utriainen, Lotta; Al-Mossawi, Mohammad Hussein; Payeli, Sravan; Marroquin, Osiris; Milling, Simon; Renner, Christoph; Bowness, Paul (2014). Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply. Annals of the Rheumatic Diseases, 73(4):763-770.

Al-Shamisi, M

Maciejewska Rodrigues, H; Al-Shamisi, M; Hemmatazad, H; Ospelt, C; Bouton, M C; Jäger, D; Cope, A P; Charles, P; Plant, D; Distler, J H W; Gay, R E; Michel, B A; Knuth, A; Neidhart, M; Gay, S; Jüngel, A (2010). Functional autoantibodies against serpin E2 in rheumatoid arthritis. Arthritis and Rheumatism, 62(1):93-104.

Albany, Costantine

Feldman, Darren R; Lorch, Anja; Kramar, Andrew; Albany, Costantine; Einhorn, Lawrence H; Giannatempo, Patrizia; Necchi, Andrea; Flechon, Aude; Boyle, Helen; Chung, Peter; Huddart, Robert A; Bokemeyer, Carsten; Tryakin, Alexey; Sava, Teodoro; Winquist, Eric William; De Giorgi, Ugo; Aparicio, Jorge; Sweeney, Christopher J; Cohn Cedermark, Gabriella; Beyer, Jörg; Powles, Thomas (2016). Brain metastases in patients with germ cell tumors: prognostic factors and treatment options: an analysis from the global germ cell cancer group. Journal of Clinical Oncology, 34(4):345-351.

Alberto, R

Waibel, R; Treichler, H; Schaefer, N G; van Staveren, D R; Mundwiler, S; Kunze, S; Küenzi, M; Alberto, R; Nüesch, J; Knuth, A; Moch, H; Schibli, R; Schubiger, P A (2008). New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Research, 68(8):2904-2911.

Aldape, K

Gilbert, Mark R; Dignam, James; Pugh, Stephanie; Armstrong, Terri S; Wefel, Jeffrey S; Aldape, K; Stupp, Roger; Hegi, Monika; Won, Minhee; Curran, Walter J; Mehta, Minesh (2014). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 32(15):1634-1635.

Aldape, Ken

Weller, Michael; Wick, Wolfgang; Aldape, Ken; Brada, Michael; Berger, Mitchell; Pfister, Stefan M; Nishikawa, Ryo; Rosenthal, Mark; Wen, Patrick Y; Stupp, Roger; Reifenberger, Guido (2015). Glioma. Nature Reviews. Disease Primers, (2015):15017.

Aldape, Kenneth D

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Alexander, Helen

Seifert, Heike; Georgiou, Alexandros; Alexander, Helen; McLachlan, Jennifer; Bodla, Shankar; Kaye, Stan; Barton, Desmond; Nobbenhuis, Marielle; Gore, Martin; Banerjee, Susana (2015). Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). Gynecologic Oncology, 139(2):216-220.

Alexandru, H

Rordorf, T; Hassan, A A; Azim, H; Alexandru, H; Er, O; Gokmen, E; Güral, Z; Mardiak, J; Minchev, V; Peintinger, F; Szendroi, M; Takac, I; Tesarova, P; Vorobiof, D; Vrbanec, D; Yildiz, R; Yücel, S; Zekri, J; Oyan, B (2014). Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup. Breast, 23(5):511-525.

Alikhanyan, K

Pitter, K L; Tamagno, I; Alikhanyan, K; Hosni-Ahmed, A; Pattwell, S S; Donnola, S; Dai, C; Ozawa, T; Chang, M; Chan, T A; Beal, K; Bishop, A J; Barker, C A; Jones, T S; Hentschel, B; Gorlia, T; Schlegel, U; Stupp, R; Weller, M; Holland, E C; Hambardzumyan, D (2016). Corticosteroids compromise survival in glioblastoma. Brain, 139(Pt 5):1458-1471.

Alix, Philippe

Wislet-Gendebien, Sabine; Laudet, Emerence; Neirinckx, Virginie; Alix, Philippe; Leprince, Pierre; Glejzer, Aneta; Poulet, Christophe; Hennuy, Benoit; Sommer, Lukas; Shakhova, Olga; Rogister, Bernard (2012). Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cellular and Molecular Life Sciences, 69(15):2593-2608.

Alkadhi, H

Reiner, C S; Goetti, R; Burger, I A; Fischer, M A; Frauenfelder, T; Knuth, A; Pfammatter, T; Schaefer, N; Alkadhi, H (2012). Liver perfusion imaging in patients with primary and metastatic liver malignancy: prospective comparison between 99mTc-MAA spect and dynamic CT perfusion. Academic Radiology, 19(5):613-621.

Goetti, R; Reiner, C S; Knuth, A; Klotz, E; Stenner, F; Samaras, P; Alkadhi, H (2012). Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound. Investigative Radiology, 47(1):18-24.

Goetti, R; Leschka, S; Desbiolles, L; Klotz, E; Samaras, P; von Boehmer, L; Stenner, F; Reiner, C; Stolzmann, P; Scheffel, H; Knuth, A; Marincek, B; Alkadhi, H (2010). Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases. Investigative Radiology, 45(7):419-426.

Alkadhi, Hatem

Morsbach, Fabian; Pfammatter, Thomas; Reiner, Caecilia S; Fischer, Michael A; Sah, Bert-Ram; Winklhofer, Sebastian; Klotz, Ernst; Frauenfelder, Thomas; Knuth, Alexander; Seifert, Burkhardt; Schaefer, Niklaus; Alkadhi, Hatem (2013). Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Investigative Radiology, 48(11):787-794.

Gnannt, Ralph; Winklehner, Anna; Eberli, Daniel; Knuth, Alexander; Frauenfelder, Thomas; Alkadhi, Hatem (2012). Automated tube potential selection for standard chest and abdominal CT in follow-up patients with testicular cancer: comparison with fixed tube potential. European Radiology, 22(9):1937-1945.

Allegrini, P R

Oehler, C; Frei, K; Rushin, E J; McSheehy, P M J; Weber, D; Allegrini, P R; Weniger, D; Lütolf, U M; Knuth, A; Yonekawa, Y; Barath, K; Broggini-Tenzer, A; Pruschy, M; Hofer, S (2012). Patupilone (Epothilone B) for recurrent glioblastoma: Clinical outcome and translational analysis of a single-institution phase I/II trial. Oncology, 83(1):1-9.

Alles, J

Motsch, N; Alles, J; Imig, J; Zhu, J; Barth, S; Reineke, T; Tinguely, M; Cogliatti, S; Dueck, A; Meister, G; Renner, C; Grässer, F A (2012). MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS ONE, 7(8):e42193.

Alles, Julia

Kwanhian, Wiyada; Lenze, Dido; Alles, Julia; Motsch, Natalie; Barth, Stephanie; Döll, Celina; Imig, Jochen; Hummel, Michael; Tinguely, Marianne; Trivedi, Pankaj; Lulitanond, Viraphong; Meister, Gunter; Renner, Christoph; Grässer, Friedrich A (2012). MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Medicine, 1(2):141-155.

Allmann, V

Fankhauser, C D; Curioni-Fontecedro, A; Allmann, V; Beyer, J; Tischler, V; Sulser, T; Moch, H; Bode, P K (2015). Frequent PD-L1 expression in testicular germ cell tumors. British Journal of Cancer, 113(3):411-413.

Allo, Ghassan

Bitanihirwe, Byron K Y; Meerang, Mayura; Friess, Martina; Soltermann, Alex; Frischknecht, Lukas; Thies, Svenja; Felley-Bosco, Emanuela; Tsao, Ming-Sound; Allo, Ghassan; de Perrot, Marc; Seifert, Burkhardt; Moch, Holger; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2014). PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. Journal of Thoracic Oncology, 9(2):239-247.

Altevogt, Peter

Fankhauser, Christian D; Bode, Peter K; Hermanns, Thomas; Sander, Sophia; Beyer, Joerg; Sulser, Tullio; Altevogt, Peter; Moch, Holger; Tischler, Verena (2016). L1-CAM is commonly expressed in testicular germ cell tumours. Journal of Clinical Pathology, 69(5):460-462.

Amadori, D

Carteni, G; Manegold, C; Martin Garcia, G; Siena, S; Zielinski, C C; Amadori, D; Liu, Y; Blatter, J; Visseren-Grul, C; Stahel, R (2009). Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent. Lung Cancer, 64(2):211-218.

Amaral, Teresa

Morgan, Gilberto; Lambertini, Matteo; Kourie, Hampig Raphael; Amaral, Teresa; Argiles, Guillem; Banerjee, Susana; Cardone, Claudia; Corral, Jesus; De Mattos-Arruda, Letticia; Öztürk, Akif; Petrova, Mila; Poulsen, Laurids; Strijbos, Michiel; Tyulyandina, Alexandra; Vidra, Radu; Califano, Raffaele; de Azambuja, Evandro; Garrido Lopez, Pilar; Guarneri, Valentina; Reck, Martin; Moiseyenko, Vladimir; Martinelli, Erika; Douillard, Jean-Yves; Stahel, Rolf; Voest, Emile; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo; Cervantes, Andrés; Eggermont, Alexander M M; et al (2016). Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open, 1:e000107.

Ampollini, L

Ampollini, L; Soltermann, A; Felley-Bosco, E; Lardinois, D; Arni, S; Speck, R F; Weder, W; Opitz, I (2009). Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting. European Journal of Cardio-Thoracic Surgery, 35(3):457-462.

Amthauer, H

Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Král, Z; Fuchs, M; Hallek, M; Kanz, L; Döhner, H; Dörken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, H T; Müller, R P; Dietlein, M; Borchmann, P; Diehl, V (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet, 379(9828):1791-1799.

Anchisi, S

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollar, A; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V; Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26(4):709-714.

Anderson, Kenneth

Doroshow, James H; Sleijfer, Stefan; Stupp, Roger; Anderson, Kenneth (2013). Cancer clinical trials - do we need a new algorithm in the age of stratified medicine? The oncologist, 18(6):651-652.

Andratschke, N

Gulden-Sala, W; Roth, P; Brown, M; Andratschke, N; Weller, M; Stupp, R (2016). Gliome – was ich wissen muss in zehn Fragen. Praxis, 105(6):330-337.

Andreesen, R

Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Král, Z; Fuchs, M; Hallek, M; Kanz, L; Döhner, H; Dörken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, H T; Müller, R P; Dietlein, M; Borchmann, P; Diehl, V (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet, 379(9828):1791-1799.

Andreoni, Wanda

Kroes, Jaap M H; Pietrucci, Fabio; Curioni, Alessandro; Andreoni, Wanda (2014). Characterizing and understanding divalent adsorbates on carbon nanotubes with ab initio and classical approaches: size, chirality, and coverage effects. Journal of Chemical Theory and Computation, 10(10):4672-4683.

Antico, Andrea

Vegro, Mara; Eccher, Giulia; Populin, Francesca; Sorgato, Chiara; Savazzini, Federica; Pagliarani, Giulia; Tartarini, Stefano; Pasini, Gabriella; Curioni, Andrea; Antico, Andrea; Botton, Alessandro (2016). Old apple (malus domestica L. Borkh) varieties with hypoallergenic properties: an integrated approach for studying apple allergenicity. Journal of Agricultural and Food Chemistry, 64(48):9224-9236.

Aparicio, Jorge

Fischer, Stefanie; Tandstad, Torgrim; Wheater, Matthew; Porfiri, Emilio; Fléchon, Aude; Aparicio, Jorge; Klingbiel, Dirk; Skrbinc, Breda; Basso, Umberto; Shamash, Jonathan; Lorch, Anja; Dieckmann, Klaus-Peter; Cohn-Cedermark, Gabriella; Ståhl, Olof; Chau, Caroline; Arriola, Edurne; Marti, Kalena; Hutton, Paul; Laguerre, Brigitte; Maroto, Pablo; Beyer, Jörg; Gillessen, Silke (2017). Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. Journal of Clinical Oncology, 35(2):194-200.

Feldman, Darren R; Lorch, Anja; Kramar, Andrew; Albany, Costantine; Einhorn, Lawrence H; Giannatempo, Patrizia; Necchi, Andrea; Flechon, Aude; Boyle, Helen; Chung, Peter; Huddart, Robert A; Bokemeyer, Carsten; Tryakin, Alexey; Sava, Teodoro; Winquist, Eric William; De Giorgi, Ugo; Aparicio, Jorge; Sweeney, Christopher J; Cohn Cedermark, Gabriella; Beyer, Jörg; Powles, Thomas (2016). Brain metastases in patients with germ cell tumors: prognostic factors and treatment options: an analysis from the global germ cell cancer group. Journal of Clinical Oncology, 34(4):345-351.

Apel, Barbara

Ernst, Jutta; Ikenberg, Kristian; Apel, Barbara; Schumann, Desiree M; Huber, Gerhard; Studer, Gabriela; Rordorf, Tamara; Riesterer, Oliver; Rössle, Matthias; Korol, Dimitri; Bredell, Marius G (2016). Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue. OncoTarget, 7(46):76151-76158.

Arai, Yoshio

Kondziolka, Douglas; Parry, Phillip V; Lunsford, L Dade; Kano, Hideyuki; Flickinger, John C; Rakfal, Susan; Arai, Yoshio; Loeffler, Jay S; Rush, Stephen; Knisely, Jonathan P S; Sheehan, Jason; Friedman, William; Tarhini, Ahmad A; Francis, Lanie; Lieberman, Frank; Ahluwalia, Manmeet S; Linskey, Mark E; McDermott, Michael; Sperduto, Paul; Stupp, Roger (2014). The accuracy of predicting survival in individual patients with cancer. Journal of Neurosurgery, 120(1):24-30.

Arbogast, S

Arbogast, S; Behnke, S; Opitz, I; Stahel, R A; Seifert, B; Weder, W; Moch, H; Soltermann, A (2011). Automated ERCC1 Immunohistochemistry in Non-small Cell Lung Cancer: Comparison of anti-ERCC1 Antibodies 8F1, D-10, and FL-297. Applied Immunohistochemistry & Molecular Morphology, 19(2):99-105.

Ardizzoni, Andrea

Gridelli, Cesare; de Marinis, Filippo; Di Maio, Massimo; Ardizzoni, Andrea; Belani, Chandra P; Cappuzzo, Federico; Ciardiello, Fortunato; Fidias, Panagiotis; Paz-Ares, Luis; Perrone, Francesco; Pirker, Robert; De Petris, Luigi; Stahel, Rolf (2012). Maintenance treatment of advanced non-small-cell lung cancer: Results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Lung Cancer, 76(3):269-279.

Arellano, J

Body, J; Henry, D; von Moos, R; Rider, A; De Courcy, J; Murray, G; Bhowmik, D; Gatta, F; Arellano, J; Hechmati, G; Qian, Y (2015). Bone pain and bone targeting agent (Bta) treatment pattern in patients with bone metastases (Bms) from prostate cancer (Pc) in real world setting in Europe. Value in Health, 18(7):A493.

Arenas-Ramirez, Natalia

Zingg, Daniel; Debbache, Julien; Schaefer, Simon M; Tuncer, Eylul; Frommel, Sandra C; Cheng, Phil; Arenas-Ramirez, Natalia; Haeusel, Jessica; Zhang, Yudong; Bonalli, Mario; McCabe, Michael T; Creasy, Caretha L; Levesque, Mitchell P; Boyman, Onur; Santoro, Raffaella; Shakhova, Olga; Dummer, Reinhard; Sommer, Lukas (2015). The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nature Communications, 6:6051.

Argiles, Guillem

Morgan, Gilberto; Lambertini, Matteo; Kourie, Hampig Raphael; Amaral, Teresa; Argiles, Guillem; Banerjee, Susana; Cardone, Claudia; Corral, Jesus; De Mattos-Arruda, Letticia; Öztürk, Akif; Petrova, Mila; Poulsen, Laurids; Strijbos, Michiel; Tyulyandina, Alexandra; Vidra, Radu; Califano, Raffaele; de Azambuja, Evandro; Garrido Lopez, Pilar; Guarneri, Valentina; Reck, Martin; Moiseyenko, Vladimir; Martinelli, Erika; Douillard, Jean-Yves; Stahel, Rolf; Voest, Emile; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo; Cervantes, Andrés; Eggermont, Alexander M M; et al (2016). Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open, 1:e000107.

Arikkat, J

Scharl, M; Mwinyi, J; Fischbeck, A; Leucht, K; Eloranta, J J; Arikkat, J; Pesch, T; Kellermeier, S; Mair, A; Kullak-Ublick, G A; Truninger, K; Noreen, F; Regula, J; Gaj, P; Pittet, V; Mueller, C; Hofmann, C; Fried, M; McCole, D F; Rogler, G (2012). Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflammatory Bowel Diseases, 18(5):900-912.

Scharl, M; Wojtal, K A; Becker, H M; Fischbeck, A; Frei, P; Arikkat, J; Pesch, T; Kellermeier, S; Boone, D L; Weber, A; Loessner, M J; Vavricka, S R; Fried, M; McCole, D F; Rogler, G (2012). Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflammatory Bowel Diseases, 18(7):1287-1302.

Scharl, M; Leucht, K; Frey-Wagner, I; Zeitz, J; Hausmann, M; Fischbeck, A; Liebisch, G; Kellermeier, S; Pesch, T; Arikkat, J; Schmitz, G; Fried, M; Yildiz, Y; Rogler, G (2011). Knock-out of β-glucosidase 2 has no influence on dextran sulfate sodium-induced colitis. Digestion, 84(2):156-167.

Armstrong, Terri S

Gilbert, Mark R; Dignam, James; Pugh, Stephanie; Armstrong, Terri S; Wefel, Jeffrey S; Aldape, K; Stupp, Roger; Hegi, Monika; Won, Minhee; Curran, Walter J; Mehta, Minesh (2014). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 32(15):1634-1635.

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Arni, S

Ampollini, L; Soltermann, A; Felley-Bosco, E; Lardinois, D; Arni, S; Speck, R F; Weder, W; Opitz, I (2009). Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting. European Journal of Cardio-Thoracic Surgery, 35(3):457-462.

Arni, Stephan

Meerang, Mayura; Bérard, Karima; Felley-Bosco, Emanuela; Lauk, Olivia; Vrugt, Bart; Boss, Andreas; Kenkel, David; Broggini-Tenzer, Angela; Stahel, Rolf A; Arni, Stephan; Weder, Walter; Opitz, Isabelle (2016). Antagonizing the hedgehog pathway with vismodegib impairs malignant pleural mesothelioma growth in vivo by affecting stroma. Molecular Cancer Therapeutics, 15(5):1095-1105.

Arnold, D

Pentheroudakis, G; Cardoso, F; Arnold, D; Sessa, C; Peters, S; Horwich, A; Pavlidis, N; Stahel, R; Cervantes, A (2015). The ESMO guideline strategy: an identity statement and reflections on improvement. Annals of Oncology, 26 Suppl:v1-v7.

Ciardiello, F; Arnold, D; Casali, P G; Cervantes, A; Douillard, J-Y; Eggermont, A; Eniu, A; McGregor, K; Peters, S; Piccart, M; Popescu, R; Van Cutsem, E; Zielinski, C; Stahel, R (2014). Delivering Precision Medicine in Oncology Today and in Future-The Promise and Challenges of Personalised Cancer Medicine: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(9):1673-1678.

Arnold, Dirk

Morgan, Gilberto; Lambertini, Matteo; Kourie, Hampig Raphael; Amaral, Teresa; Argiles, Guillem; Banerjee, Susana; Cardone, Claudia; Corral, Jesus; De Mattos-Arruda, Letticia; Öztürk, Akif; Petrova, Mila; Poulsen, Laurids; Strijbos, Michiel; Tyulyandina, Alexandra; Vidra, Radu; Califano, Raffaele; de Azambuja, Evandro; Garrido Lopez, Pilar; Guarneri, Valentina; Reck, Martin; Moiseyenko, Vladimir; Martinelli, Erika; Douillard, Jean-Yves; Stahel, Rolf; Voest, Emile; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo; Cervantes, Andrés; Eggermont, Alexander M M; et al (2016). Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open, 1:e000107.

Arnold, I

Craig, V J; Arnold, I; Gerke, C; Huynh, M Q; Wundisch, T; Neubauer, A; Renner, C; Falkow, S; Mueller, A (2010). Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood, 115(3):581-591.

Arriola, Edurne

Fischer, Stefanie; Tandstad, Torgrim; Wheater, Matthew; Porfiri, Emilio; Fléchon, Aude; Aparicio, Jorge; Klingbiel, Dirk; Skrbinc, Breda; Basso, Umberto; Shamash, Jonathan; Lorch, Anja; Dieckmann, Klaus-Peter; Cohn-Cedermark, Gabriella; Ståhl, Olof; Chau, Caroline; Arriola, Edurne; Marti, Kalena; Hutton, Paul; Laguerre, Brigitte; Maroto, Pablo; Beyer, Jörg; Gillessen, Silke (2017). Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. Journal of Clinical Oncology, 35(2):194-200.

Asslaber, M

Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A (2014). A functional germline variant in GLI1 implicates Hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clinical Cancer Research, 20(6):1687-1697.

Astoul, P

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Pe'choux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 13(10):C23-C45.

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Péchoux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma. European Respiratory Journal, 35:479-495.

Atanackovic, Djordje

Nuber, Natko; Curioni-Fontecedro, Alessandra; Dannenmann, Stefanie R; Matter, C; von Boehmer, Lotta; Atanackovic, Djordje; Knuth, Alexander; van den Broek, Maries (2013). MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients. Leukemia, 27(8):1767-1769.

Atmaca, A

Karbach, J; Neumann, A; Atmaca, A; Wahle, C; Brand, K; von Boehmer, L; Knuth, A; Bender, A; Ritter, G; Old, L J; Jäger, E (2011). Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients. Clinical Cancer Research, 17(4):861-870.

Atmaca, A; Al-Batran, S E; Neumann, A; Kolassa, Y; Jäger, D; Knuth, A; Jäger, E (2009). Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - A phase II study. Gynecologic oncology, 112(2):384-388.

Al-Batran, S E; Hartmann, J T; Probst, S; Schmalenberg, H; Hollerbach, S; Hofheinz, R; Rethwisch, V; Seipelt, G; Homann, N; Wilhelm, G; Schuch, G; Stoehlmacher, J; Derigs, H G; Hegewisch-Becker, S; Grossmann, J; Pauligk, C; Atmaca, A; Bokemeyer, C; Knuth, A; Jäger, E (2008). Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. Journal of Clinical Oncology, 26(9):1435-1442.

von Minckwitz, G; Harder, S; Hövelmann, S; Jäger, E; Al-Batran, S E; Loibl, S G; Atmaca, A; Cimpoiasu, C; Neumann, A M; Abera, A; Knuth, A L; Kaufmann, M; Jäger, D; Maurer, A B; Wels, W S (2005). Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas. Breast Cancer Research, 7(5):R617-R626.

Atrott, Kirstin

Kiessling, Michael K; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Atrott, Kirstin; Cosin-Roger, Jesus; Lang, Silvia; Scharl, Michael; Rogler, Gerhard (2015). Mutant HRAS as novel target for MEK and mTOR inhibitors. OncoTarget, 6(39):42183-42196.

Attig, S

Widenmeyer, M; Griesemann, H; Stevanović, S; Feyerabend, S; Klein, R; Attig, S; Hennenlotter, J; Wernet, D; Kuprash, D V; Sazykin, A Y; Pascol, S; Stenzl, A; Gouttefangeas, C; Rammensee, H G (2012). Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients. International Journal of Cancer, 131(1):140-149.

Audisio, C

Audisio, C; Stahel, V; Aapro, M S; Costa, A; Pandey, M; Pavlidis, N (2008). Successful publishing: How to get your paper accepted. Surgical Oncology, 18(4):350-356.

Audisio, R A

Pavlidis, N; Vermorken, J B; Stahel, R; Bernier, J; Cervantes, A; Pentheroudakis, G; Audisio, R A; Costa, A (2012). Undergraduate training in oncology: An ESO continuing challenge for medical students. Surgical Oncology, 21(1):15-21.

Aust, Daniela

Lacombe, Denis; Tejpar, Sabine; Salgado, Roberto; Cardoso, Fatima; Golfinopoulos, Vassilis; Aust, Daniela; Folprecht, Gunnar; Roth, Arnaud; Stupp, Roger (2014). European perspective for effective cancer drug development. Nature Reviews. Clinical Oncology, 11(8):492-498.

Awada, Ahmad

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi; De Santis, Maria; de Vries, Elisabeth G E; Dizon, Don S; Duff, Jennifer; Duska, Linda R; Eniu, Alexandru; et al (2016). ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 1(5):e000097.

Azim, H

Rordorf, T; Hassan, A A; Azim, H; Alexandru, H; Er, O; Gokmen, E; Güral, Z; Mardiak, J; Minchev, V; Peintinger, F; Szendroi, M; Takac, I; Tesarova, P; Vorobiof, D; Vrbanec, D; Yildiz, R; Yücel, S; Zekri, J; Oyan, B (2014). Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup. Breast, 23(5):511-525.

Baas, P

Besse, B; Adjei, A; Baas, P; Meldgaard, P; Nicolson, M; Paz-Ares, L; Reck, M; Smit, E F; Syrigos, K; Stahel, R; Felip, E; Peters, S (2014). 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Annals of Oncology, 25(8):1475-1484.

Felip, E; Gridelli, C; Baas, P; Rosell, R; Stahel, R (2011). Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010. Annals of Oncology, 22(7):1507-1519.

Weder, W; Stahel, R A; Baas, P; Dafni, U; de Perrot, M; McCaughan, B C; Nakano, T; Pass, H I; Robinson, B W S; Rusch, V W; Sugarbaker, D J; van Zandwijk, N (2011). The MARS feasibility trial: conclusions not supported by data. Lancet Oncology, 12(12):1093-1094; author reply 1094.

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Pe'choux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 13(10):C23-C45.

Stahel, R; Baas, P; Faivre-Finn, C; Dooms, C; Passlick, B; Mazières, J; Cappuzzo, F; Früh, M; Sorensen, J B; Blackhall, F; Taron, M; Gridelli, C; O'Byrne, K; Rosell, R (2010). Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP). Lung Cancer, 68(1):121-124.

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Péchoux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma. European Respiratory Journal, 35:479-495.

Santoro, A; O'Brien, M E; Stahel, R A; Nackaerts, K; Baas, P; Karthaus, M; Eberhardt, W; Paz-Ares, L; Sundstrom, S; Liu, Y; Ripoche, V; Blatter, J; Visseren-Grul, C M; Manegold, C (2008). Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program. Journal of Thoracic Oncology, 3(7):756-763.

Baas, Paul

Peters, Solange; Weder, Walter; Dafni, Urania; Kerr, Keith M; Bubendorf, Lukas; Meldgaard, Peter; O'Byrne, Kenneth J; Wrona, Anna; Vansteenkiste, Johan; Felip, Enriqueta; Marchetti, Antonio; Savic, Spasenija; Lu, Shun; Smit, Egbert; Dingemans, Anne-Marie; Blackhall, Fiona H; Baas, Paul; Camps, Carlos; Rosell, Rafael; Stahel, Rolf A (2014). Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. Journal of Thoracic Oncology, 9(11):1675-1684.

Stahel, Rolf; Peters, Solange; Baas, Paul; Brambilla, Elisabeth; Cappuzzo, Federico; De Ruysscher, Dirk; Eberhardt, Wilfried Ernst Erich; Felip, Enriqueta; Fennell, Dean; Marchetti, Antonio; Paz-Ares, Luis; Adjei, Alex A (2013). Strategies for improving outcomes in NSCLC: a look to the future. Lung Cancer, 82(3):375-382.

Bacanovic, Sara

Bacanovic, Sara; Stiller, Ruth; Pircher, Magdalena; Burger, Irene A; Huellner, Martin W (2016). Ovarian hyperstimulation and oocyte harvesting prior to systemic chemotherapy-a possible pitfall in 18F-FDG PET/CT staging of oncologic patients. Clinical Nuclear Medicine, 41(8):e394-e396.

Bachmann, M F

Speiser, D E; Schwarz, K; Baumgaertner, P; Conzett, K B; Manolova, V; Devevre, E; Sterry, W; Walden, P; Zippelius, A; Senti, G; Voelter, V; Cerottini, J P; Guggisberg, D; Willers, J; Geldhof, C; Romero, P; Kündig, T; Knuth, A; Dummer, R; Trefzer, U; Bachmann, M F (2010). Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. Journal of Immunotherapy, 33(8):848-858.

Back, Michael

Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; Bromberg, Jacoline E C; Mason, Warren P; Hoang-Xuan, Khê; Ryan, Gail; Hassel, Mohamed Ben; Enting, Roelien H; Brandes, Alba A; Wick, Antje; Chinot, Olivier; Reni, Michele; Kantor, Guy; Thiessen, Brian; Klein, Martin; Verger, Eugenie; Borchers, Christian; Hau, Peter; Back, Michael; Smits, Anja; Golfinopoulos, Vassilis; Gorlia, Thierry; Bottomley, Andrew; Stupp, Roger; Baumert, Brigitta G (2016). Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1533-1542.

Bader, Jürgen

Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica, 101(3):346-355.

Bady, P

Kurscheid, S; Bady, P; Sciuscio, D; Samarzija, I; Shay, T; Vassallo, I; Criekinge, W V; Daniel, R T; van den Bent, M J; Marosi, C; Weller, M; Mason, W P; Domany, E; Stupp, R; Delorenzi, M; Hegi, M E (2015). Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma. Genome Biology, 16(1):16.

Hegi, M E; Diserens, A C; Bady, P; Kamoshima, Y; Kouwenhoven, M C; Delorenzi, M; Lambiv, W L; Hamou, M F; Matter, M S; Koch, A; Heppner, F L; Yonekawa, Y; Merlo, A; Frei, K; Mariani, L; Hofer, S (2011). Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib - a phase II trial. Molecular Cancer Therapeutics, 10(6):1102-1112.

Bady, Pierre

Wick, Wolfgang; Gorlia, Thierry; Bady, Pierre; Platten, Michael; van den Bent, Martin J; Taphoorn, Martin J B; Steuve, Jonathan; Brandes, Alba A; Hamou, Marie-France; Wick, Antje; Kosch, Markus; Weller, Michael; Stupp, Roger; Roth, Patrick; Golfinopoulos, Vassilis; Frenel, Jean-Sebastien; Campone, Mario; Ricard, Damien; Marosi, Christine; Villà, Salvador; Weyerbrock, Astrid; Hopkins, Kirsten; Homicsko, Krisztian; Lhermitte, Benoit; Pesce, Gianfranco Angelo; Hegi, Monika E (2016). Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research, 22(19):4797-4806.

Weller, Michael; Nabors, Louis Burt; Gorlia, Thierry; Leske, Henning; Rushing, Elisabeth; Bady, Pierre; Hicking, Christine; Perry, James; Hong, Yong-Kil; Roth, Patrick; Wick, Wolfgang; Goodman, Simon L; Hegi, Monika E; Picard, Martin; Moch, Holger; Straub, Josef; Stupp, Roger (2016). Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. OncoTarget, 7(12):15018-15032.

De Meyer, Tim; Bady, Pierre; Trooskens, Geert; Kurscheid, Sebastian; Bloch, Jocelyne; Kros, Johan M; Hainfellner, Johannes A; Stupp, Roger; Delorenzi, Mauro; Hegi, Monika E; Van Criekinge, Wim (2015). Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison. Scientific Reports, 5:15375.

Baertschi, D

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollar, A; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V; Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26(4):709-714.

Bahra, M

Riener, M O; Stenner, F; Liewen, H; Soll, C; Breitenstein, S; Pestalozzi, B C; Samaras, P; Probst-Hensch, N M; Hellerbrand, C; Müllhaupt, B; Clavien, P A; Bahra, M; Neuhaus, P; Wild, P; Fritzsche, F; Moch, H; Jochum, W; Kristiansen, G (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49(5):1602 -1609.

Bajetta, E

Bernhard, J; Dietrich, D; Scheithauer, W; Gerber, D; Bodoky, G; Ruhstaller, T; Glimelius, B; Bajetta, E; Schüller, J; Saletti, P; Bauer, J; Figer, A; Pestalozzi, B C; Köhne, C H; Mingrone, W; Stemmer, S M; Tàmas, K; Kornek, G V; Koeberle, D; Herrmann, R (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial - SAKK 44/00-CECOG/PAN.1.3.001. Journal of Clinical Oncology, 26(22):3695-3701.

Balakumaran, Arun

von Moos, Roger; Body, Jean-Jacques; Egerdie, Blair; Stopeck, Alison; Brown, Janet; Fallowfield, Lesley; Patrick, Donald L; Cleeland, Charles; Damyanov, Danail; Palazzo, Felipe Salvador; Marx, Gavin; Zhou, Ying; Braun, Ada; Balakumaran, Arun; Qian, Yi (2016). Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer, 24(3):1327-1337.

Balana, Carmen

Baumert, Brigitta G; Hegi, Monika E; van den Bent, Martin J; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khê; Brandes, Alba A; Kantor, Guy; Taphoorn, Martin J B; Hassel, Mohamed Ben; Hartmann, Christian; Ryan, Gail; Capper, David; Kros, Johan M; Kurscheid, Sebastian; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline E; Feuvret, Loic; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Johanna M M; Rossiter, John P; Dif, Nicolas; Balana, Carmen; Bravo-Marques, Jose; Clement, Paul M; et al (2016). Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1521-1532.

Ballmer-Weber, B K

Petrausch, U; Pircher, M; Reding, Daniel; Ballmer-Weber, B K; Pestalozzi, Bernhard C (2015). Deactivation to antineoplastic agents. Schweizer Krebsbulletin, 2015(1):42-44.

Banerjee, Susana

Morgan, Gilberto; Lambertini, Matteo; Kourie, Hampig Raphael; Amaral, Teresa; Argiles, Guillem; Banerjee, Susana; Cardone, Claudia; Corral, Jesus; De Mattos-Arruda, Letticia; Öztürk, Akif; Petrova, Mila; Poulsen, Laurids; Strijbos, Michiel; Tyulyandina, Alexandra; Vidra, Radu; Califano, Raffaele; de Azambuja, Evandro; Garrido Lopez, Pilar; Guarneri, Valentina; Reck, Martin; Moiseyenko, Vladimir; Martinelli, Erika; Douillard, Jean-Yves; Stahel, Rolf; Voest, Emile; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo; Cervantes, Andrés; Eggermont, Alexander M M; et al (2016). Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open, 1:e000107.

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi; De Santis, Maria; de Vries, Elisabeth G E; Dizon, Don S; Duff, Jennifer; Duska, Linda R; Eniu, Alexandru; et al (2016). ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 1(5):e000097.

Seifert, Heike; Georgiou, Alexandros; Alexander, Helen; McLachlan, Jennifer; Bodla, Shankar; Kaye, Stan; Barton, Desmond; Nobbenhuis, Marielle; Gore, Martin; Banerjee, Susana (2015). Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). Gynecologic Oncology, 139(2):216-220.

Bangrad, C

Bangrad, C Hämatologie und Onkologie : fallorientierte Darstellung - rationale Diagnostik und Therapie. Edited by: Kreuzer, Karl-Anton; Beyer, Jörg (2016). Stuttgart: Thieme Verlag.

Bansky, G

Vavricka, S R; Schoepfer, A M; Bansky, G; Binek, J; Felley, C; Geyer, M; Manz, M; Rogler, G; de Saussure, P; Sauter, B; Scharl, M; Seibold, F; Straumann, A; Michetti, P (2011). Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflammatory Bowel Diseases, 17(7):1530-1539.

Baran-Schmidt, R

Braun, S; Oppermann, H; Mueller, A; Renner, C; Hovhannisyan, A; Baran-Schmidt, R; Gebhardt, R; Hipkiss, A; Thiery, J; Meixensberger, J; Gaunitz, F (2012). Hedgehog signaling in glioblastoma multiforme. Cancer Biology & Therapy, 13(7):487-495.

Barath, K

Oehler, C; Frei, K; Rushin, E J; McSheehy, P M J; Weber, D; Allegrini, P R; Weniger, D; Lütolf, U M; Knuth, A; Yonekawa, Y; Barath, K; Broggini-Tenzer, A; Pruschy, M; Hofer, S (2012). Patupilone (Epothilone B) for recurrent glioblastoma: Clinical outcome and translational analysis of a single-institution phase I/II trial. Oncology, 83(1):1-9.

Barbone, D

Echeverry, N; Ziltener, G; Barbone, D; Weder, W; Stahel, R A; Broaddus, V C; Felley-Bosco, E (2015). Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death and Disease, 6:e1757.

Bargetzi, M

Renner, C; Zinzani, P L; Gressin, R; Klingbiel, D; Dietrich, P Y; Hitz, P; Bargetzi, M; Mingrone, W; Martinelli, G; Trojan, A; Bouabdallah, K; Lohri, A; Gyan, E; Biaggi, C; Cogliatti, S; Bertoni, F; Ghielmini, M; Brauchli, P; Ketterer, N (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica, 97(7):1085-1091.

Bargetzi, Mario

Maul, Julia-Tatjana; Stenner-Liewen, Frank; Seifert, Burkhardt; Pfrommer, Sarah; Petrausch, Ulf; Kiessling, Michael K; Schanz, Urs; Nair, Gayathri; Mischo, Axel; Taverna, Christian; Schmidt, Adrian; Bargetzi, Mario; Stupp, Roger; Renner, Christoph; Samaras, Panagiotis (2017). Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients. Journal of clinical apheresis, 32(1):21-26.

Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss Medical Weekly, 145:w14100.

Samaras, Panagiotis; Pfrommer, Sarah; Seifert, Burkhardt; Petrausch, Ulf; Mischo, Axel; Schmidt, Adrian; Schanz, Urs; Nair, Gayathri; Bargetzi, Mario; Taverna, Christian; Stupp, Roger; Stenner-Liewen, Frank; Renner, Christoph (2015). Efficacy of vinorelbine plus G-CSF for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma. Biology of Blood and Marrow Transplantation, 21(1):74-80.

Barghorn, A

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Barker, C A

Pitter, K L; Tamagno, I; Alikhanyan, K; Hosni-Ahmed, A; Pattwell, S S; Donnola, S; Dai, C; Ozawa, T; Chang, M; Chan, T A; Beal, K; Bishop, A J; Barker, C A; Jones, T S; Hentschel, B; Gorlia, T; Schlegel, U; Stupp, R; Weller, M; Holland, E C; Hambardzumyan, D (2016). Corticosteroids compromise survival in glioblastoma. Brain, 139(Pt 5):1458-1471.

Barlesi, Fabrice

Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massutí, Bartomeu; Palmero, Ramon; Aix, Santiago Ponce; Carcereny, Enric; Früh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios; Cuffe, Sinead; Bidoli, Paolo; Favaretto, Adolfo; Froesch, Patrizia; Reguart, Noemí; Puente, Javier; Coate, Linda; Barlesi, Fabrice; Rauch, Daniel; Thomas, Michael; Camps, Carlos; Gómez-Codina, Jose; Majem, Margarita; Porta, Rut; Shah, Riyaz; Hanrahan, Emer; et al (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Lancet Respiratory Medicine, 5(5):435-444.

Barnett, Gene H

Stupp, Roger; Taillibert, Sophie; Kanner, Andrew A; Kesari, Santosh; Steinberg, David M; Toms, Steven A; Taylor, Lynne P; Lieberman, Frank; Silvani, Antonio; Fink, Karen L; Barnett, Gene H; Zhu, Jay-Jiguang; Henson, John W; Engelhard, Herbert H; Chen, Thomas C; Tran, David D; Sroubek, Jan; Tran, Nam D; Hottinger, Andreas F; Landolfi, Joseph; Desai, Rajiv; Caroli, Manuela; Kew, Yvonne; Honnorat, Jerome; Idbaih, Ahmed; Kirson, Eilon D; Weinberg, Uri; Palti, Yoram; Hegi, Monika E; Ram, Zvi (2015). Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA : the Journal of the American Medical Association, 314(23):2535-2543.

Barrandon, Yann

Shakhova, Olga; Zingg, Daniel; Schaefer, Simon M; Hari, Lisette; Civenni, Gianluca; Blunschi, Jacqueline; Claudinot, Stéphanie; Okoniewski, Michal; Beermann, Friedrich; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Dummer, Reinhard; Barrandon, Yann; Cinelli, Paolo; Sommer, Lukas (2012). Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nature Cell Biology, 14(8):882-890.

Barth, J

Stiefel, F; Barth, J; Bensing, J; Fallowfield, L; Jost, L; Razavi, D; Kiss, A (2010). Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Annals of Oncology, 21(2):204-207.

Barth, S

Motsch, N; Alles, J; Imig, J; Zhu, J; Barth, S; Reineke, T; Tinguely, M; Cogliatti, S; Dueck, A; Meister, G; Renner, C; Grässer, F A (2012). MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS ONE, 7(8):e42193.

Imig, J; Motsch, N; Zhu, J Y; Barth, S; Okoniewski, M; Reineke, T; Tinguely, M; Faggioni, A; Trivedi, P; Meister, G; Renner, C; Grässer, F A (2011). microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Research, 39(5):1880-.1893.

Barth, Stephanie

Kwanhian, Wiyada; Lenze, Dido; Alles, Julia; Motsch, Natalie; Barth, Stephanie; Döll, Celina; Imig, Jochen; Hummel, Michael; Tinguely, Marianne; Trivedi, Pankaj; Lulitanond, Viraphong; Meister, Gunter; Renner, Christoph; Grässer, Friedrich A (2012). MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Medicine, 1(2):141-155.

Barthel, Christiane

Madanchi, Mehdi; Zeitz, Jonas; Barthel, Christiane; Samaras, Panagiotis; Scharl, Sylvie; Sulz, Michael C; Biedermann, Luc; Frei, Pascal; Vavricka, Stephan R; Rogler, Gerhard; Scharl, Michael (2016). Malignancies in patients with inflammatory bowel disease: a single-centre experience. Digestion, 94(1):1-8.

Barton, Desmond

Seifert, Heike; Georgiou, Alexandros; Alexander, Helen; McLachlan, Jennifer; Bodla, Shankar; Kaye, Stan; Barton, Desmond; Nobbenhuis, Marielle; Gore, Martin; Banerjee, Susana (2015). Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). Gynecologic Oncology, 139(2):216-220.

Barysch, Marjam J

Barysch, Marjam J; Levesque, Mitchell P; Cheng, Phil; Karpova, Maria B; Mihic-Probst, Daniela; Civenni, Gianluca; Shakhova, Olga; Sommer, Lukas; Biedermann, Thomas; Schiestl, Clemens; Dummer, Reinhard (2014). Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients. Dermatopathology, 1(1):35-46.

Walter, Anne; Barysch, Marjam J; Behnke, Silvia; Dziunycz, Piotr; Schmid, Bruno; Ritter, Erika; Gnjatic, Sacha; Kristiansen, Glen; Moch, Holger; Knuth, Alexander; Dummer, Reinhard; van den Broek, Maries (2010). Cancer testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Clinical Cancer Research, 16(14):3562-3570.

Basler, Michael

Moebius, Jacqueline; van den Broek, Maries; Groettrup, Marcus; Basler, Michael (2010). Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice. European Journal of Immunology, 40(12):3439-3449.

Bass, Annatina

Kasenda, Benjamin; Bass, Annatina; Koeberle, Dieter; Pestalozzi, Bernhard; Borner, Markus; Herrmann, Richard; Jost, Lorenz; Lohri, Andreas; Hess, Viviane (2014). Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer, 14:728.

Bassi, S

Martinelli, G; Schmitz, S F H; Utiger, U; Cerny, T; Hess, U; Bassi, S; Okkinga, E; Stupp, R; Stahel, R; Heizmann, M; Vorobiof, D; Lohri, A; Dietrich, P Y; Zucca, E; Ghielmini, M (2010). Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98. Journal of Clinical Oncology, 28(29):4480-4484.

Basso, Umberto

Fischer, Stefanie; Tandstad, Torgrim; Wheater, Matthew; Porfiri, Emilio; Fléchon, Aude; Aparicio, Jorge; Klingbiel, Dirk; Skrbinc, Breda; Basso, Umberto; Shamash, Jonathan; Lorch, Anja; Dieckmann, Klaus-Peter; Cohn-Cedermark, Gabriella; Ståhl, Olof; Chau, Caroline; Arriola, Edurne; Marti, Kalena; Hutton, Paul; Laguerre, Brigitte; Maroto, Pablo; Beyer, Jörg; Gillessen, Silke (2017). Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. Journal of Clinical Oncology, 35(2):194-200.

Battegay, Edouard

Wagner, Claudia C; Held, Ulrike; Kofmehl, Reto; Battegay, Edouard; Zimmerli, Lukas; Hofer, Silvia (2014). Role of arterial hypertension as a predictive marker for bevacizumab efficacy in recurrent glioblastoma - a prospective analysis. Acta Oncologica, 53(4):572-575.

Baty, F

Joerger, M; Baty, F; Früh, M; Droege, C; Stahel, R A; Betticher, D C; von Moos, R; Ochsenbein, A; Pless, M; Gautschi, O; Rothschild, S; Brauchli, P; Klingbiel, D; Zappa, F; Brutsche, M (2014). Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer, 85(2):306-313.

Baty, Florent

Gachechiladze, Mariam; Škarda, Josef; Kolek, Vítězslav; Grygárková, Ivona; Langová, Kateřina; Bouchal, Jan; Kolář, Zdeněk; Baty, Florent; Stahel, Rolf; Weder, Walter; Soltermann, Alex; Joerger, Markus (2017). Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer, 105:31-38.

Gautschi, Oliver; Dingemans, Anne-Marie; Crowe, Susanne; Peters, Solange; Roder, Heinrich; Grigorieva, Julia; Roder, Joanna; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Baty, Florent; Bubendorf, Lukas; Hsu Schmitz, Shu-Fang; Na, Kyung-Jae; Carbone, David; Stahel, Rolf; Smit, Egbert (2013). VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer, 79(1):59-64.

Baudis, M

Peralta, R; Baudis, M; Vazquez, G; Juárez, S; Ortiz, R; Decanini, H; Hernandez, D; Gallegos, F; Valdivia, A; Piña, P; Salcedo, M (2010). Increased expression of cellular retinol-binding protein 1 in laryngeal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology, 136(6):931-938.

Bauer, J

Bernhard, J; Dietrich, D; Scheithauer, W; Gerber, D; Bodoky, G; Ruhstaller, T; Glimelius, B; Bajetta, E; Schüller, J; Saletti, P; Bauer, J; Figer, A; Pestalozzi, B C; Köhne, C H; Mingrone, W; Stemmer, S M; Tàmas, K; Kornek, G V; Koeberle, D; Herrmann, R (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial - SAKK 44/00-CECOG/PAN.1.3.001. Journal of Clinical Oncology, 26(22):3695-3701.

Bauer, S

Brokopp, C E; Schoenauer, R; Richards, P; Bauer, S; Lohmann, C; Emmert, M Y; Weber, B; Winnik, S; Aikawa, E; Graves, K; Genoni, M; Vogt, P; Luscher, T F; Renner, C; Hoerstrup, S P; Matter, C M (2011). Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. European Heart Journal, 32(21):2713-2722.

Samaras, P; Blickenstorfer, M; Haile, S R; Siciliano, D; Petrausch, U; Mischo, A; Zweifel, M; Honegger, H; Schanz, U; Stüssi, G; Taverna, C; Bauer, S; Knuth, A; Stenner-Liewen, F; Renner, C (2011). Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss Medical Weekly, 141:w13203.

Ospelt, C; Mertens, J C; Jüngel, A; Brentano, F; Maciejewska Rodrigues, H; Huber, L C; Hemmatazad, H; Wüest, T; Knuth, A; Gay, R E; Michel, B A; Gay, S; Renner, C; Bauer, S (2010). Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 62(5):1224-1235.

Thiel, M; Wolfs, M J; Bauer, S; Wenning, A S; Burckhart, T; Schwarz, E C; Scott, A M; Renner, C; Hoth, M (2010). Efficiency of T-cell costimulation by CD80 and CD86 cross-linking correlates with calcium entry. Immunology, 129(1):28-40.

Bauer, S; Oosterwijk-Wakka, J C; Adrian, N; Oosterwijk, E; Fischer, E; Wüest, T; Stenner, F; Perani, A; Cohen, L S; Knuth, A; Divgi, C; Jäger, D; Scott, A M; Ritter, G; Old, L J; Renner, C (2009). Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg. International Journal of Cancer, 125(1):115-123.

Stewart-Jones, G; Wadle, A; Hombach, A; Shenderov, E; Held, G; Fischer, E; Kleber, S; Stenner-Liewen, F; Bauer, S; McMichael, A; Knuth, A; Abken, H; Hombach, A A; Cerundolo, V; Jones, E Y; Renner, C (2009). Rational development of high-affinity T-cell receptor-like antibodies. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(14):5784-5788.

Bauer, S; Adrian, N; Siebenborn, U; Fadle, N; Plesko, M; Fischer, E; Wüest, T; Stenner, F; Mertens, J C; Knuth, A; Ritter, G; Old, L J; Renner, C (2009). Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8. Cancer Immunity, 9(2):1-10.

Stenner, F; Liewen, H; Zweifel, M; Weber, A; Tchinda, J; Bode, B; Samaras, P; Bauer, S; Knuth, A; Renner, C (2008). Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo. Cancer Science, 99(9):1847-1852.

Bauer, Stefan

Stenner, Frank; Liewen, Heike; Göttig, Stephan; Henschler, Reinhard; Markuly, Norbert; Kleber, Sascha; Faust, Michael; Mischo, Axel; Bauer, Stefan; Zweifel, Martin; Knuth, Alexander; Renner, Christoph; Wadle, Andreas (2013). RP1 is a phosphorylation target of CK2 and is involved in cell adhesion. PLoS ONE, 8(7):e67595.

Fischer, Eliane; Chaitanya, Krishna; Wüest, Thomas; Wadle, Andreas; Scott, Andrew M; van den Broek, Maries; Schibli, Roger; Bauer, Stefan; Renner, Christoph (2012). Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. Clinical Cancer Research, 18(22):6208-6218.

Bauerfeind, P

Heinrich, S; Pestalozzi, B C; Schäfer, M; Weber, A; Bauerfeind, P; Knuth, A; Clavien, P A (2008). Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology, 26(15):2526-2531.

Baumert, Brigitta

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Baumert, Brigitta G

Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; Bromberg, Jacoline E C; Mason, Warren P; Hoang-Xuan, Khê; Ryan, Gail; Hassel, Mohamed Ben; Enting, Roelien H; Brandes, Alba A; Wick, Antje; Chinot, Olivier; Reni, Michele; Kantor, Guy; Thiessen, Brian; Klein, Martin; Verger, Eugenie; Borchers, Christian; Hau, Peter; Back, Michael; Smits, Anja; Golfinopoulos, Vassilis; Gorlia, Thierry; Bottomley, Andrew; Stupp, Roger; Baumert, Brigitta G (2016). Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1533-1542.

Baumert, Brigitta G; Hegi, Monika E; van den Bent, Martin J; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khê; Brandes, Alba A; Kantor, Guy; Taphoorn, Martin J B; Hassel, Mohamed Ben; Hartmann, Christian; Ryan, Gail; Capper, David; Kros, Johan M; Kurscheid, Sebastian; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline E; Feuvret, Loic; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Johanna M M; Rossiter, John P; Dif, Nicolas; Balana, Carmen; Bravo-Marques, Jose; Clement, Paul M; et al (2016). Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1521-1532.

Gorlia, Thierry; Wu, Wenting; Wang, Meihua; Baumert, Brigitta G; Mehta, Minesh; Buckner, Jan C; Shaw, Edward; Brown, Paul; Stupp, Roger; Galanis, Evanthia; Lacombe, Denis; van den Bent, Martin J (2013). New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro-Oncology, 15(11):1568-1579.

Baumgaertner, P

Speiser, D E; Schwarz, K; Baumgaertner, P; Conzett, K B; Manolova, V; Devevre, E; Sterry, W; Walden, P; Zippelius, A; Senti, G; Voelter, V; Cerottini, J P; Guggisberg, D; Willers, J; Geldhof, C; Romero, P; Kündig, T; Knuth, A; Dummer, R; Trefzer, U; Bachmann, M F (2010). Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. Journal of Immunotherapy, 33(8):848-858.

Baumgartner, Martin

Kumar, Karthiga Santhana; Pillong, Max; Kunze, Jens; Burghardt, Isabel; Weller, Michael; Grotzer, Michael A; Schneider, Gisbert; Baumgartner, Martin (2015). Computer-assisted quantification of motile and invasive capabilities of cancer cells. Scientific Reports, 5:15338.

Bausch-Fluck, D

Ziegler, A; Cerciello, F; Bigosch, C; Bausch-Fluck, D; Felley-Bosco, E; Ossola, R; Soltermann, A; Stahel, R A; Wollscheid, B (2012). Proteomic surfaceome analysis of mesothelioma. Lung Cancer, 75(2):189-196.

Bausch-Fluck, Damaris

Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasits, Ulrich; Gundry, Rebekah L; Yoon, Charles; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Härtlová, Anetta; Van Eyk, Jennifer E; Bourquin, Jean-Pierre; Aebersold, Ruedi; Boheler, Kenneth R; Zandstra, Peter; Wollscheid, Bernd (2015). A mass spectrometric-derived cell surface protein atlas. PLoS ONE, 10(3):e0121314.

Cerciello, Ferdinando; Choi, Meena; Nicastri, Annalisa; Bausch-Fluck, Damaris; Ziegler, Annemarie; Vitek, Olga; Felley-Bosco, Emanuela; Stahel, Rolf; Aebersold, Ruedi; Wollscheid, Bernd (2013). Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring. Clinical Proteomics, 10:16.

Beal, K

Pitter, K L; Tamagno, I; Alikhanyan, K; Hosni-Ahmed, A; Pattwell, S S; Donnola, S; Dai, C; Ozawa, T; Chang, M; Chan, T A; Beal, K; Bishop, A J; Barker, C A; Jones, T S; Hentschel, B; Gorlia, T; Schlegel, U; Stupp, R; Weller, M; Holland, E C; Hambardzumyan, D (2016). Corticosteroids compromise survival in glioblastoma. Brain, 139(Pt 5):1458-1471.

Beck, Joachim

Laurent, Julien; Touvrey, Cedric; Gillessen, Silke; Joffraud, Magali; Vicari, Manuela; Bertrand, Caroline; Ongarello, Stefano; Liedert, Bernd; Gallerani, Elisa; Beck, Joachim; Omlin, Aurelius; Sessa, Cristiana; Quaratino, Sonia; Stupp, Roger; Gnad-Vogt, Ulrike S; Speiser, Daniel E (2013). T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein. Journal of Translational Medicine, 11:5.

Beck-Schimmer, Beatrice

Piegeler, Tobias; Winder, Thomas; Kern, Sabine; Pestalozzi, Bernhard; Schneider, Paul Magnus; Beck-Schimmer, Beatrice (2016). Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch(®) system: An observational feasibility study. Oncology Letters, 12(2):1513-1518.

Becker, H M

Scharl, M; Wojtal, K A; Becker, H M; Fischbeck, A; Frei, P; Arikkat, J; Pesch, T; Kellermeier, S; Boone, D L; Weber, A; Loessner, M J; Vavricka, S R; Fried, M; McCole, D F; Rogler, G (2012). Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflammatory Bowel Diseases, 18(7):1287-1302.

Bedke, Jens

Lukamowicz-Rajska, Magdalena; Mittmann, Christiane; Prummer, Michael; Zhong, Qing; Bedke, Jens; Hennenlotter, Jörg; Stenzl, Arnulf; Mischo, Axel; Bihr, Svenja; Schmidinger, Manuela; Vogl, Ursula; Blume, Iris; Karlo, Christoph; Schraml, Peter; Moch, Holger (2016). MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. OncoTarget:15.

Beer, Hans-Dietmar

Walter, Anne; Schäfer, Matthias; Cecconi, Virginia; Matter, Claudia; Urosevic-Maiwald, Mirjana; Belloni, Benedetta; Schönewolf, Nicola; Dummer, Reinhard; Bloch, Wilhelm; Werner, Sabine; Beer, Hans-Dietmar; Knuth, Alexander; van den Broek, Maries (2013). Aldara activates TLR7-independent immune defence. Nature Communications, 4:1560.

Beermann, Friedrich

Shakhova, Olga; Zingg, Daniel; Schaefer, Simon M; Hari, Lisette; Civenni, Gianluca; Blunschi, Jacqueline; Claudinot, Stéphanie; Okoniewski, Michal; Beermann, Friedrich; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Dummer, Reinhard; Barrandon, Yann; Cinelli, Paolo; Sommer, Lukas (2012). Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nature Cell Biology, 14(8):882-890.

Behnke, S

Arbogast, S; Behnke, S; Opitz, I; Stahel, R A; Seifert, B; Weder, W; Moch, H; Soltermann, A (2011). Automated ERCC1 Immunohistochemistry in Non-small Cell Lung Cancer: Comparison of anti-ERCC1 Antibodies 8F1, D-10, and FL-297. Applied Immunohistochemistry & Molecular Morphology, 19(2):99-105.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Behnke, Silvia

Walter, Anne; Barysch, Marjam J; Behnke, Silvia; Dziunycz, Piotr; Schmid, Bruno; Ritter, Erika; Gnjatic, Sacha; Kristiansen, Glen; Moch, Holger; Knuth, Alexander; Dummer, Reinhard; van den Broek, Maries (2010). Cancer testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Clinical Cancer Research, 16(14):3562-3570.

Belani, Chandra P

Gridelli, Cesare; de Marinis, Filippo; Di Maio, Massimo; Ardizzoni, Andrea; Belani, Chandra P; Cappuzzo, Federico; Ciardiello, Fortunato; Fidias, Panagiotis; Paz-Ares, Luis; Perrone, Francesco; Pirker, Robert; De Petris, Luigi; Stahel, Rolf (2012). Maintenance treatment of advanced non-small-cell lung cancer: Results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Lung Cancer, 76(3):269-279.

Belloni, Benedetta

Cheng, Phil F; Shakhova, Olga; Widmer, Daniel S; Eichhoff, Ossia M; Zingg, Daniel; Frommel, Sandra C; Belloni, Benedetta; Raaijmakers, Marieke Ig; Goldinger, Simone M; Santoro, Raffaella; Hemmi, Silvio; Sommer, Lukas; Dummer, Reinhard; Levesque, Mitchell P (2015). Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biology, 16:42.

Walter, Anne; Schäfer, Matthias; Cecconi, Virginia; Matter, Claudia; Urosevic-Maiwald, Mirjana; Belloni, Benedetta; Schönewolf, Nicola; Dummer, Reinhard; Bloch, Wilhelm; Werner, Sabine; Beer, Hans-Dietmar; Knuth, Alexander; van den Broek, Maries (2013). Aldara activates TLR7-independent immune defence. Nature Communications, 4:1560.

Belousov, P V

Shebzukhov, Y V; Lavrik, I N; Karbach, J; Khlgatian, S V; Koroleva, B P; Belousov, P V; Kashkin, K N; Knuth, A; Jager, E; Chi, N W; Kuprash, D V; Nedospasov, S A (2008). Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients. Cancer Immunology, Immunotherapy, 57(6):871-881.

Belyanskaya, L L

Belyanskaya, L L; Ziogas, A; Hopkins-Donaldson, S; Kurtz, S; Simon, H U; Stahel, R; Zangemeister-Wittke, U (2008). TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8. Lung Cancer, 60(3):355-365.

Bender, A

Karbach, J; Neumann, A; Atmaca, A; Wahle, C; Brand, K; von Boehmer, L; Knuth, A; Bender, A; Ritter, G; Old, L J; Jäger, E (2011). Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients. Clinical Cancer Research, 17(4):861-870.

Benlloch, S

Patton, S; Normanno, N; Blackhall, F; Murray, S; Kerr, K M; Dietel, M; Filipits, M; Benlloch, S; Popat, S; Stahel, R; Thunnissen, E (2014). Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. British Journal of Cancer, 111(2):413-420.

Bensing, J

Stiefel, F; Barth, J; Bensing, J; Fallowfield, L; Jost, L; Razavi, D; Kiss, A (2010). Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Annals of Oncology, 21(2):204-207.

Bentele, N

Vavricka, S R; Bentele, N; Scharl, M; Rogler, G; Zeitz, J; Frei, P; Straumann, A; Binek, J; Schoepfer, A M; Fried, M (2012). Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL). Inflammatory Bowel Diseases, 18(8):1523-1530.

Berardi, R

Dittrich, C; Kosty, M; Jezdic, S; Pyle, D; Berardi, R; Bergh, J; El Saghir, N; Lotz, J-P; Österlund, P; Pavlidis, N; Purkalne, G; ESMO/ASCO Global Curriculum Working Group (2016). ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016. Annals of Oncology, 27(8):1378-1381.

Berardi, Rossana

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi; De Santis, Maria; de Vries, Elisabeth G E; Dizon, Don S; Duff, Jennifer; Duska, Linda R; Eniu, Alexandru; et al (2016). ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 1(5):e000097.

Berardi Vilei, Simona

Hitz, Felicitas; Zucca, Emanuele; Pabst, Thomas; Fischer, Natalie; Cairoli, Anne; Samaras, Panagiotis; Caspar, Clemens B; Mach, Nicolas; Krasniqi, Fatime; Schmidt, Adrian; Rothermundt, Christian; Enoiu, Milica; Eckhardt, Katrin; Berardi Vilei, Simona; Rondeau, Stephanie; Mey, Ulrich (2016). Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. British Journal of Haematology, 174(2):255-263.

Berger, Lars A

Berger, Lars A; Bokemeyer, Carsten; Lorch, Anja; Hentrich, Marcus; Kopp, Hans‑Georg; Gauler, Thomas C; Beyer, Jörg; de Wit, Maike; Mayer, Frank; Boehlke, Ina; Oing, Christoph; Honecker, Friedemann; Oechsle, Karin (2014). First salvage treatment in patients with advanced germ cell cancer after cisplatin‑based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Journal of Cancer Research and Clinical Oncology, 140(7):1211-1220.

Berger, Lars Arne

Oing, Christoph; Lorch, Anja; Bokemeyer, Carsten; Honecker, Friedemann; Beyer, Jörg; Berger, Lars Arne; Oechsle, Karin (2015). First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database. Journal of Cancer Research and Clinical Oncology, 141(5):923-931.

Berger, Mitchel S

Jarzabek, Monika A; Sweeney, Kieron J; Evans, Rhys L; Jacobs, Andreas H; Stupp, Roger; O'Brien, Donncha; Berger, Mitchel S; Prehn, Jochen H M; Byrne, Annette T (2013). Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary. Drug Discovery Today, 18(21-22):1052-1066.

Berger, Mitchell

Weller, Michael; Wick, Wolfgang; Aldape, Ken; Brada, Michael; Berger, Mitchell; Pfister, Stefan M; Nishikawa, Ryo; Rosenthal, Mark; Wen, Patrick Y; Stupp, Roger; Reifenberger, Guido (2015). Glioma. Nature Reviews. Disease Primers, (2015):15017.

Bergh, J

Dittrich, C; Kosty, M; Jezdic, S; Pyle, D; Berardi, R; Bergh, J; El Saghir, N; Lotz, J-P; Österlund, P; Pavlidis, N; Purkalne, G; ESMO/ASCO Global Curriculum Working Group (2016). ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016. Annals of Oncology, 27(8):1378-1381.

Eiermann, W; Bergh, J; Cardoso, F; Conte, P; Crown, J; Curtin, N J; Gligorov, J; Gusterson, B; Joensuu, H; Linderholm, B K; Martin, M; Penault-Llorca, F; Pestalozzi, B C; Razis, E; Sotiriou, C; Tjulandin, S; Viale, G (2012). Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design. Breast, 21(1):20-26.

Bergh, Jonas

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi; De Santis, Maria; de Vries, Elisabeth G E; Dizon, Don S; Duff, Jennifer; Duska, Linda R; Eniu, Alexandru; et al (2016). ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 1(5):e000097.

Berghmans, T

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Pe'choux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 13(10):C23-C45.

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Péchoux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma. European Respiratory Journal, 35:479-495.

Berghmans, Thierry

Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; Sanchez, Ramón Palmero; Villa Guzmán, José Carlos; Martin, Ricardo Collado; Peralta, Sergio; Insa, Amelia; Summers, Yvonne; Láng, István; Horgan, Anne; Ciardiello, Fortunato; de Hosson, Sander; et al (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of Thoracic Oncology, 12(4):752-762.

Bergthaler, A

Flatz, L; Hegazy, A N; Bergthaler, A; Verschoor, A; Claus, C; Fernandez-Rivas, M; Gattinoni, L; Johnson, S; Kreppel, F; Kochanek, S; Broek, M; Radbruch, A; Lévy, F; Lambert, P H; Siegrist, C A; Restifo, N P; Löhning, M; Ochsenbein, A F; Nabel, G J; Pinschewer, D D (2010). Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nature Medicine, 16(3):339-345.

Bernhard, J

Pagani, O; Klingbiel, D; Ruhstaller, T; Nolè, F; Eppenberger, S; Oehlschlegel, C; Bernhard, J; Brauchli, P; Hess, D; Mamot, C; Munzone, E; Pestalozzi, B; Rabaglio, M; Aebi, S; Ribi, K; Rochlitz, C; Rothgiesser, K; Thürlimann, B; Moos, R von; Zaman, K; Goldhirsch, A; Swiss Group for Clinical Cancer Research (SAKK) (2017). Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized Phase III trial SAKK 22/99. Annals of Oncology, 28(2):305-312.

Ribi, K; Bernhard, J; Schuller, J C; Weder, W; Bodis, S; Jörger, M; Betticher, D; Schmid, R A; Stupp, R; Ris, H B; Stahel, R A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer, 61(3):398-404.

Bernhard, J; Dietrich, D; Scheithauer, W; Gerber, D; Bodoky, G; Ruhstaller, T; Glimelius, B; Bajetta, E; Schüller, J; Saletti, P; Bauer, J; Figer, A; Pestalozzi, B C; Köhne, C H; Mingrone, W; Stemmer, S M; Tàmas, K; Kornek, G V; Koeberle, D; Herrmann, R (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial - SAKK 44/00-CECOG/PAN.1.3.001. Journal of Clinical Oncology, 26(22):3695-3701.

Bernier, J

Pavlidis, N; Vermorken, J B; Stahel, R; Bernier, J; Cervantes, A; Pentheroudakis, G; Audisio, R A; Costa, A (2012). Undergraduate training in oncology: An ESO continuing challenge for medical students. Surgical Oncology, 21(1):15-21.

Berset, Catherine

Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica, 101(3):346-355.

Berthod, Gregoire

Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica, 101(3):346-355.

Bertoni, F

Renner, C; Zinzani, P L; Gressin, R; Klingbiel, D; Dietrich, P Y; Hitz, P; Bargetzi, M; Mingrone, W; Martinelli, G; Trojan, A; Bouabdallah, K; Lohri, A; Gyan, E; Biaggi, C; Cogliatti, S; Bertoni, F; Ghielmini, M; Brauchli, P; Ketterer, N (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica, 97(7):1085-1091.

Bertran-Alamillo, J

Salazar, F; Molina, M A; Sanchez-Ronco, M; Moran, T; Ramirez, J L; Sanchez, J M; Stahel, R; Garrido, P; Cobo, M; Isla, D; Bertran-Alamillo, J; Massuti, B; Cardenal, F; Manegold, C; Lianes, P; Trigo, J M; Sanchez, J J; Taron, M; Rosell, R (2011). First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients. Lung Cancer, 72(1):84-91.

Bertrand, Caroline

Laurent, Julien; Touvrey, Cedric; Gillessen, Silke; Joffraud, Magali; Vicari, Manuela; Bertrand, Caroline; Ongarello, Stefano; Liedert, Bernd; Gallerani, Elisa; Beck, Joachim; Omlin, Aurelius; Sessa, Cristiana; Quaratino, Sonia; Stupp, Roger; Gnad-Vogt, Ulrike S; Speiser, Daniel E (2013). T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein. Journal of Translational Medicine, 11:5.

Besse, B

Besse, B; Adjei, A; Baas, P; Meldgaard, P; Nicolson, M; Paz-Ares, L; Reck, M; Smit, E F; Syrigos, K; Stahel, R; Felip, E; Peters, S (2014). 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Annals of Oncology, 25(8):1475-1484.

Gridelli, C; Stahel, R; Besse, B; Ciardiello, F; Felip, E; Gasparini, S; Graziano, P; Rossi, A; de Marinis, F (2011). Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting. Lung Cancer, 74(3):544-548.

Besse, Benjamin

Gautschi, Oliver; Milia, Julie; Cabarrou, Bastien; Bluthgen, Marie-Virginia; Besse, Benjamin; Smit, Egbert F; Wolf, Juergen; Peters, Solange; Früh, Martin; Koeberle, Dieter; Oulkhouir, Youssouf; Schuler, Martin; Curioni-Fontecedro, Alessandra; Huret, Benjamin; Kerjouan, Mallorie; Michels, Sebastian; Pall, Georg; Rothschild, Sacha; Schmid-Bindert, Gerald; Scheffler, Matthias; Veillon, Rémi; Wannesson, Luciano; Diebold, Joachim; Zalcman, Gérard; Filleron, Thomas; Mazières, Julien (2015). Targeted therapy for patients with BRAF-mutant lung cancer: results from the european EURAF cohort. Journal of Thoracic Oncology, 10(10):1451-1457.

Betticher, D

Strasser, F; Blum, D; von Moos, R; Cathomas, R; Ribi, K; Aebi, S; Betticher, D; Hayoz, S; Klingbiel, D; Brauchli, P; Haefner, M; Mauri, S; Kaasa, S; Koeberle, D (2016). The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Annals of Oncology, 27(2):324-332.

Zappa, F; Droege, C; Betticher, D; von Moos, R; Bubendorf, L; Ochsenbein, A; Gautschi, O; Oppliger Leibundgut, E; Froesch, P; Stahel, R; Hess, T; Rauch, D; Schmid, P; Mayer, M; Crowe, S; Brauchli, P; Ribi, K; Pless, M (2012). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05). Lung Cancer, 78(3):239-244.

Ribi, K; Bernhard, J; Schuller, J C; Weder, W; Bodis, S; Jörger, M; Betticher, D; Schmid, R A; Stupp, R; Ris, H B; Stahel, R A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer, 61(3):398-404.

Betticher, D C

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollar, A; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V; Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26(4):709-714.

Joerger, M; Baty, F; Früh, M; Droege, C; Stahel, R A; Betticher, D C; von Moos, R; Ochsenbein, A; Pless, M; Gautschi, O; Rothschild, S; Brauchli, P; Klingbiel, D; Zappa, F; Brutsche, M (2014). Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer, 85(2):306-313.

Stupp, R; Mayer, M; Kann, R; Weder, W; Zouhair, A; Betticher, D C; Roth, A D; Stahel, R A; Majno, S; Peters, S; Jost, L; Furrer, M; Thierstein, S; Schmid, R A; Hsu-Schmitz, S F; Mirimanoff, R O; Ris, H B; Pless, M (2009). Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncology, 10(8):785-793.

D'Addario, G; Rauch, D; Stupp, R; Pless, M; Stahel, R; Mach, N; Jost, L; Widmer, L; Tapia, C; Bihl, M; Mayer, M; Ribi, K; Lerch, S; Bubendorf, L; Betticher, D C (2008). Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of Oncology, 19(4):739-745.

Betticher, Daniel C

Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian F; Swiss Group for Clinical Cancer Research (2017). Bevacizumab plus pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous non-small-cell lung cancer: Update from the swiss group for clinical cancer research (SAKK) 19/09 trial. Clinical Lung Cancer, 18(3):303-309.

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; Peters, Solange (2015). Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 386(9998):1049-1056.

Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss Medical Weekly, 145:w14100.

Beyeler, Michael

Stahel, Rolf A; Riesterer, Oliver; Xyrafas, Alexandros; Opitz, Isabelle; Beyeler, Michael; Ochsenbein, Adrian; Früh, Martin; Cathomas, Richard; Nackaerts, Kristiaan; Peters, Solange; Mamot, Christoph; Zippelius, Alfred; Mordasini, Carlo; Caspar, Clemens B; Eckhardt, Katrin; Schmid, Ralph A; Aebersold, Daniel M; Gautschi, Oliver; Nagel, Wolfgang; Töpfer, Michael; Krayenbuehl, Jerome; Ribi, Karin; Ciernik, Llja F; Weder, Walter (2015). Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncology, 16(16):1651-1658.

Beyer, J

Beyer, J (2016). Therapie muskelinvasiver und metastasierter Tumoren. info@onkologie, 5:20-23.

Beyer, J (2016). Urogenitale Tumoren („non-prostate“). Leading Opinions, 4:56-58.

Fankhauser, C D; Curioni-Fontecedro, A; Allmann, V; Beyer, J; Tischler, V; Sulser, T; Moch, H; Bode, P K (2015). Frequent PD-L1 expression in testicular germ cell tumors. British Journal of Cancer, 113(3):411-413.

Beyer, Joerg

Fankhauser, Christian D; Bode, Peter K; Hermanns, Thomas; Sander, Sophia; Beyer, Joerg; Sulser, Tullio; Altevogt, Peter; Moch, Holger; Tischler, Verena (2016). L1-CAM is commonly expressed in testicular germ cell tumours. Journal of Clinical Pathology, 69(5):460-462.

Beyer, Jörg

Fischer, Stefanie; Tandstad, Torgrim; Wheater, Matthew; Porfiri, Emilio; Fléchon, Aude; Aparicio, Jorge; Klingbiel, Dirk; Skrbinc, Breda; Basso, Umberto; Shamash, Jonathan; Lorch, Anja; Dieckmann, Klaus-Peter; Cohn-Cedermark, Gabriella; Ståhl, Olof; Chau, Caroline; Arriola, Edurne; Marti, Kalena; Hutton, Paul; Laguerre, Brigitte; Maroto, Pablo; Beyer, Jörg; Gillessen, Silke (2017). Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. Journal of Clinical Oncology, 35(2):194-200.

Lorch, Anja; Beyer, Jörg (2016). High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how. World Journal of Urology:Epub ahead of print.

Feldman, Darren R; Lorch, Anja; Kramar, Andrew; Albany, Costantine; Einhorn, Lawrence H; Giannatempo, Patrizia; Necchi, Andrea; Flechon, Aude; Boyle, Helen; Chung, Peter; Huddart, Robert A; Bokemeyer, Carsten; Tryakin, Alexey; Sava, Teodoro; Winquist, Eric William; De Giorgi, Ugo; Aparicio, Jorge; Sweeney, Christopher J; Cohn Cedermark, Gabriella; Beyer, Jörg; Powles, Thomas (2016). Brain metastases in patients with germ cell tumors: prognostic factors and treatment options: an analysis from the global germ cell cancer group. Journal of Clinical Oncology, 34(4):345-351.

Oing, Christoph; Lorch, Anja; Bokemeyer, Carsten; Honecker, Friedemann; Beyer, Jörg; Berger, Lars Arne; Oechsle, Karin (2015). First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database. Journal of Cancer Research and Clinical Oncology, 141(5):923-931.

Beyer, Jörg (2014). Miracles don`t happen any more. Annals of Oncology, 25(9):1679-1680.

Berger, Lars A; Bokemeyer, Carsten; Lorch, Anja; Hentrich, Marcus; Kopp, Hans‑Georg; Gauler, Thomas C; Beyer, Jörg; de Wit, Maike; Mayer, Frank; Boehlke, Ina; Oing, Christoph; Honecker, Friedemann; Oechsle, Karin (2014). First salvage treatment in patients with advanced germ cell cancer after cisplatin‑based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Journal of Cancer Research and Clinical Oncology, 140(7):1211-1220.

Steiner, Raphael; Beyer, Jörg (2014). CME. Suivi post-traitement des patients atteints d'une néoplasie testiculaire pour les médecins de premiers recours. Praxis, 103(3):125-132.

Steiner, Raphael; Beyer, Jörg (2014). Suivi post-traitement des patients atteints d'une néoplasie testiculaire pour les médecins de premiers recours. Praxis, 103(3):125-132.

Bhatia, Smita

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi; De Santis, Maria; de Vries, Elisabeth G E; Dizon, Don S; Duff, Jennifer; Duska, Linda R; Eniu, Alexandru; et al (2016). ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 1(5):e000097.

Bhowmik, D

Body, J; Henry, D; von Moos, R; Rider, A; De Courcy, J; Murray, G; Bhowmik, D; Gatta, F; Arellano, J; Hechmati, G; Qian, Y (2015). Bone pain and bone targeting agent (Bta) treatment pattern in patients with bone metastases (Bms) from prostate cancer (Pc) in real world setting in Europe. Value in Health, 18(7):A493.

Biaggi, C

Renner, C; Zinzani, P L; Gressin, R; Klingbiel, D; Dietrich, P Y; Hitz, P; Bargetzi, M; Mingrone, W; Martinelli, G; Trojan, A; Bouabdallah, K; Lohri, A; Gyan, E; Biaggi, C; Cogliatti, S; Bertoni, F; Ghielmini, M; Brauchli, P; Ketterer, N (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica, 97(7):1085-1091.

Biaggi, Christine

Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian F; Swiss Group for Clinical Cancer Research (2017). Bevacizumab plus pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous non-small-cell lung cancer: Update from the swiss group for clinical cancer research (SAKK) 19/09 trial. Clinical Lung Cancer, 18(3):303-309.

Bidoli, Paolo

Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massutí, Bartomeu; Palmero, Ramon; Aix, Santiago Ponce; Carcereny, Enric; Früh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios; Cuffe, Sinead; Bidoli, Paolo; Favaretto, Adolfo; Froesch, Patrizia; Reguart, Noemí; Puente, Javier; Coate, Linda; Barlesi, Fabrice; Rauch, Daniel; Thomas, Michael; Camps, Carlos; Gómez-Codina, Jose; Majem, Margarita; Porta, Rut; Shah, Riyaz; Hanrahan, Emer; et al (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Lancet Respiratory Medicine, 5(5):435-444.

Biedermann, Luc

Madanchi, Mehdi; Zeitz, Jonas; Barthel, Christiane; Samaras, Panagiotis; Scharl, Sylvie; Sulz, Michael C; Biedermann, Luc; Frei, Pascal; Vavricka, Stephan R; Rogler, Gerhard; Scharl, Michael (2016). Malignancies in patients with inflammatory bowel disease: a single-centre experience. Digestion, 94(1):1-8.

Wojtal, Kacper A; Rogler, Gerhard; Scharl, Michael; Biedermann, Luc; Frei, Pascal; Fried, Michael; Weber, Achim; Eloranta, Jyrki J; Kullak-Ublick, Gerd A; Vavricka, Stephan R (2012). Fc gamma receptor CD64 modulates the inhibitory activity of infliximab. PLoS ONE, 7(8):e43361.

Biedermann, Thomas

Barysch, Marjam J; Levesque, Mitchell P; Cheng, Phil; Karpova, Maria B; Mihic-Probst, Daniela; Civenni, Gianluca; Shakhova, Olga; Sommer, Lukas; Biedermann, Thomas; Schiestl, Clemens; Dummer, Reinhard (2014). Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients. Dermatopathology, 1(1):35-46.

Biesma, Bonne

Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; Sanchez, Ramón Palmero; Villa Guzmán, José Carlos; Martin, Ricardo Collado; Peralta, Sergio; Insa, Amelia; Summers, Yvonne; Láng, István; Horgan, Anne; Ciardiello, Fortunato; de Hosson, Sander; et al (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of Thoracic Oncology, 12(4):752-762.

Bifulco, C B

Schuberth, P C; Jakka, G; Jensen, S M; Wadle, A; Gautschi, F; Haley, D; Haile, S; Mischo, A; Held, G; Thiel, M; Tinguely, M; Bifulco, C B; Fox, B A; Renner, C; Petrausch, U (2013). Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma. Gene Therapy, 20(4):386-395.

Bigosch, C

Ziegler, A; Cerciello, F; Bigosch, C; Bausch-Fluck, D; Felley-Bosco, E; Ossola, R; Soltermann, A; Stahel, R A; Wollscheid, B (2012). Proteomic surfaceome analysis of mesothelioma. Lung Cancer, 75(2):189-196.

Bihl, M

D'Addario, G; Rauch, D; Stupp, R; Pless, M; Stahel, R; Mach, N; Jost, L; Widmer, L; Tapia, C; Bihl, M; Mayer, M; Ribi, K; Lerch, S; Bubendorf, L; Betticher, D C (2008). Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of Oncology, 19(4):739-745.

Bihr, Svenja

Lukamowicz-Rajska, Magdalena; Mittmann, Christiane; Prummer, Michael; Zhong, Qing; Bedke, Jens; Hennenlotter, Jörg; Stenzl, Arnulf; Mischo, Axel; Bihr, Svenja; Schmidinger, Manuela; Vogl, Ursula; Blume, Iris; Karlo, Christoph; Schraml, Peter; Moch, Holger (2016). MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. OncoTarget:15.

Razafinjatovo, Caroline; Bihr, Svenja; Mischo, Axel; Vogl, Ursula; Schmidinger, Manuela; Moch, Holger; Schraml, Peter (2016). Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer, 16:638.

Bijelovic, Milorad

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; Peters, Solange (2015). Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 386(9998):1049-1056.

Binek, J

Vavricka, S R; Bentele, N; Scharl, M; Rogler, G; Zeitz, J; Frei, P; Straumann, A; Binek, J; Schoepfer, A M; Fried, M (2012). Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL). Inflammatory Bowel Diseases, 18(8):1523-1530.

Vavricka, S R; Schoepfer, A M; Bansky, G; Binek, J; Felley, C; Geyer, M; Manz, M; Rogler, G; de Saussure, P; Sauter, B; Scharl, M; Seibold, F; Straumann, A; Michetti, P (2011). Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflammatory Bowel Diseases, 17(7):1530-1539.

Birnber, Tal

Yogev, Nir; Frommer, Friederike; Lukas, Dominika; Kautz-Neu, Kordula; Karram, Khalad; Ielo, Daniele; von Stebut, Esther; Probst, Hans C; van den Broek, Maries; Riethmacher, Dieter; Birnber, Tal; Blank, Thomas; Reizis, Boris; Korn, Thomas; Wiendl, Heinz; Jung, Steffen; Prinz, Marco; Kurschus, Florian C; Waisman, Ari (2012). Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity, 37(2):264-275.

Bishop, A J

Pitter, K L; Tamagno, I; Alikhanyan, K; Hosni-Ahmed, A; Pattwell, S S; Donnola, S; Dai, C; Ozawa, T; Chang, M; Chan, T A; Beal, K; Bishop, A J; Barker, C A; Jones, T S; Hentschel, B; Gorlia, T; Schlegel, U; Stupp, R; Weller, M; Holland, E C; Hambardzumyan, D (2016). Corticosteroids compromise survival in glioblastoma. Brain, 139(Pt 5):1458-1471.

Bitanihirwe, Byron K Y

Meerang, Mayura; Bérard, Karima; Friess, Martina; Bitanihirwe, Byron K Y; Soltermann, Alex; Vrugt, Bart; Felley-Bosco, Emanuela; Bueno, Raphael; Richards, William G; Seifert, Burkhardt; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2016). Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma. Molecular Oncology, 10(8):1255-1265.

Bitanihirwe, Byron K Y; Meerang, Mayura; Friess, Martina; Soltermann, Alex; Frischknecht, Lukas; Thies, Svenja; Felley-Bosco, Emanuela; Tsao, Ming-Sound; Allo, Ghassan; de Perrot, Marc; Seifert, Burkhardt; Moch, Holger; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2014). PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. Journal of Thoracic Oncology, 9(2):239-247.

Bittermann, A G

Rettig, L; Haen, S P; Bittermann, A G; von Boehmer, L; Curioni, A; Krämer, S D; Knuth, A; Pascolo, S (2010). Particle size and activation threshold: a new dimension of danger signaling. Blood, 115(22):4533-4541.

Tinguely, M; Jenni, B; Knights, A; Lopes, B; Korol, D; Rousson, V; Curioni Fontecedro, A; Cogliatti, S B; Bittermann, A G; Schmid, U; Dommann-Scherrer, C; Maurer, R; Renner, C; Probst-Hensch, N M; Moch, H; Knuth, A; Zippelius, A (2008). MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer Science, 99(4):720-725.

Bitzer, Annegret

Schliehe, Christopher; Bitzer, Annegret; van den Broek, Maries; Groettrup, Marcus (2012). Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo. Journal of Virology, 86(18):9782-9793.

Blackhall, F

Patton, S; Normanno, N; Blackhall, F; Murray, S; Kerr, K M; Dietel, M; Filipits, M; Benlloch, S; Popat, S; Stahel, R; Thunnissen, E (2014). Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. British Journal of Cancer, 111(2):413-420.

Stahel, R; Baas, P; Faivre-Finn, C; Dooms, C; Passlick, B; Mazières, J; Cappuzzo, F; Früh, M; Sorensen, J B; Blackhall, F; Taron, M; Gridelli, C; O'Byrne, K; Rosell, R (2010). Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP). Lung Cancer, 68(1):121-124.

Blackhall, Fiona

Peters, Solange; Taron, Miquel; Bubendorf, Lukas; Blackhall, Fiona; Stahel, Rolf (2013). Treatment and detection of ALK-rearranged NSCLC. Lung Cancer, 81(2):145-154.

Blackhall, Fiona H

Peters, Solange; Weder, Walter; Dafni, Urania; Kerr, Keith M; Bubendorf, Lukas; Meldgaard, Peter; O'Byrne, Kenneth J; Wrona, Anna; Vansteenkiste, Johan; Felip, Enriqueta; Marchetti, Antonio; Savic, Spasenija; Lu, Shun; Smit, Egbert; Dingemans, Anne-Marie; Blackhall, Fiona H; Baas, Paul; Camps, Carlos; Rosell, Rafael; Stahel, Rolf A (2014). Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. Journal of Thoracic Oncology, 9(11):1675-1684.

Blackhall, Fiona H; Peters, Solange; Bubendorf, Lukas; Dafni, Urania; Kerr, Keith M; Hager, Henrik; Soltermann, Alex; O'Byrne, Kenneth J; Dooms, Christoph; Sejda, Aleksandra; Hernández-Losa, Javier; Marchetti, Antonio; Savic, Spasenija; Tan, Qiang; Thunnissen, Erik; Speel, Ernst-Jan M; Cheney, Richard; Nonaka, Daisuke; de Jong, Jeroen; Martorell, Miguel; Letovanec, Igor; Rosell, Rafael; Stahel, Rolf A (2014). Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project. Journal of Clinical Oncology, 32(25):2780-2787.

Blanco, R

Rosell, R; Manegold, C; Moran, T; Garrido, P; Blanco, R; Lianes, P; Stahel, R; Trigo, J M; Wei, J; Taron, M (2008). Can We Customize Chemotherapy? Individualizing Cytotoxic Regimens in Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer, 9(Supplement 2):S76-S82.

Blank, Bernd

Thalhammer, Verena; Lopez-Garcia, Laura A; Herrero Martin, David; Hecker, Regina; Laubscher, Dominik; Gierisch, Maria E; Wachtel, Marco; Bode, Peter; Nanni, Paolo; Blank, Bernd; Koscielniak, Ewa; Schäfer, Beat W (2015). PLK1 phosphorylates PAX3-FOXO1 the inhibition of which triggers regression of alveolar rhabdomyosarcoma. Cancer Research, 75(1):98-110.

Blank, Thomas

Yogev, Nir; Frommer, Friederike; Lukas, Dominika; Kautz-Neu, Kordula; Karram, Khalad; Ielo, Daniele; von Stebut, Esther; Probst, Hans C; van den Broek, Maries; Riethmacher, Dieter; Birnber, Tal; Blank, Thomas; Reizis, Boris; Korn, Thomas; Wiendl, Heinz; Jung, Steffen; Prinz, Marco; Kurschus, Florian C; Waisman, Ari (2012). Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity, 37(2):264-275.

Blatter, J

Carteni, G; Manegold, C; Martin Garcia, G; Siena, S; Zielinski, C C; Amadori, D; Liu, Y; Blatter, J; Visseren-Grul, C; Stahel, R (2009). Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent. Lung Cancer, 64(2):211-218.

Santoro, A; O'Brien, M E; Stahel, R A; Nackaerts, K; Baas, P; Karthaus, M; Eberhardt, W; Paz-Ares, L; Sundstrom, S; Liu, Y; Ripoche, V; Blatter, J; Visseren-Grul, C M; Manegold, C (2008). Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program. Journal of Thoracic Oncology, 3(7):756-763.

Blazeby, Jane

Dirven, Linda; Taphoorn, Martin J B; Reijneveld, Jaap C; Blazeby, Jane; Jacobs, Marc; Pusic, Andrea; La Sala, Edoardo; Stupp, Roger; Fayers, Peter; Efficace, Fabio (2014). The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review. European Journal of Cancer, 50(14):2432-2448.

Blickenstorfer, M

Samaras, P; Blickenstorfer, M; Siciliano, R D; Haile, S R; Buset, E M; Petrausch, U; Mischo, A; Honegger, H; Schanz, U; Stüssi, G; Stahel, R A; Knuth, A; Stenner-Liewen, F; Renner, C (2011). Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim. Annals of Hematology, 90(1):89-94.

Samaras, P; Blickenstorfer, M; Haile, S R; Siciliano, D; Petrausch, U; Mischo, A; Zweifel, M; Honegger, H; Schanz, U; Stüssi, G; Taverna, C; Bauer, S; Knuth, A; Stenner-Liewen, F; Renner, C (2011). Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss Medical Weekly, 141:w13203.

Blievernicht, J

Schwab, M; Zanger, U M; Marx, C; Schaeffeler, E; Klein, K; Dippon, J; Kerb, R; Blievernicht, J; Fischer, J; Hofmann, U; Bokemeyer, C; Eichelbaum, M (2008). Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group. Journal of Clinical Oncology, 26(13):2131-2138.

Bloch, J

Dunet, V; Maeder, P; Nicod-Lalonde, M; Lhermitte, B; Pollo, C; Bloch, J; Stupp, R; Meuli, R; Prior, O J (2014). Combination of MRI and dynamic FET PET for initial glioma grading. Nuklearmedizin. Nuclear medicine, 53(4):155-161.

Bloch, Jocelyne

De Meyer, Tim; Bady, Pierre; Trooskens, Geert; Kurscheid, Sebastian; Bloch, Jocelyne; Kros, Johan M; Hainfellner, Johannes A; Stupp, Roger; Delorenzi, Mauro; Hegi, Monika E; Van Criekinge, Wim (2015). Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison. Scientific Reports, 5:15375.

Bloch, Wilhelm

Walter, Anne; Schäfer, Matthias; Cecconi, Virginia; Matter, Claudia; Urosevic-Maiwald, Mirjana; Belloni, Benedetta; Schönewolf, Nicola; Dummer, Reinhard; Bloch, Wilhelm; Werner, Sabine; Beer, Hans-Dietmar; Knuth, Alexander; van den Broek, Maries (2013). Aldara activates TLR7-independent immune defence. Nature Communications, 4:1560.

Block, Norman L

Hohla, Florian; Winder, Thomas; Greil, Richard; Rick, Ferenc G; Block, Norman L; Schally, Andrew V (2014). Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives. World Journal of Gastroenterology, 20(20):6102-6112.

Blum, D

Strasser, F; Blum, D; von Moos, R; Cathomas, R; Ribi, K; Aebi, S; Betticher, D; Hayoz, S; Klingbiel, D; Brauchli, P; Haefner, M; Mauri, S; Kaasa, S; Koeberle, D (2016). The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Annals of Oncology, 27(2):324-332.

Blum, Walter

Blum, Walter; Pecze, László; Felley-Bosco, Emanuela; Worthmüller-Rodriguez, Janine; Wu, Licun; Vrugt, Bart; de Perrot, Marc; Schwaller, Beat (2015). Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line. In vitro cellular & developmental biology. Animal, 51(7):714-721.

Blum, Walter; Pecze, László; Felley-Bosco, Emanuela; Schwaller, Beat (2015). Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration. Respiratory Research, 16:153.

Blume, Iris

Lukamowicz-Rajska, Magdalena; Mittmann, Christiane; Prummer, Michael; Zhong, Qing; Bedke, Jens; Hennenlotter, Jörg; Stenzl, Arnulf; Mischo, Axel; Bihr, Svenja; Schmidinger, Manuela; Vogl, Ursula; Blume, Iris; Karlo, Christoph; Schraml, Peter; Moch, Holger (2016). MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. OncoTarget:15.

Blumenthal, Deborah T

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Blunschi, Jacqueline

Shakhova, Olga; Zingg, Daniel; Schaefer, Simon M; Hari, Lisette; Civenni, Gianluca; Blunschi, Jacqueline; Claudinot, Stéphanie; Okoniewski, Michal; Beermann, Friedrich; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Dummer, Reinhard; Barrandon, Yann; Cinelli, Paolo; Sommer, Lukas (2012). Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nature Cell Biology, 14(8):882-890.

Bluthgen, Marie-Virginia

Gautschi, Oliver; Milia, Julie; Cabarrou, Bastien; Bluthgen, Marie-Virginia; Besse, Benjamin; Smit, Egbert F; Wolf, Juergen; Peters, Solange; Früh, Martin; Koeberle, Dieter; Oulkhouir, Youssouf; Schuler, Martin; Curioni-Fontecedro, Alessandra; Huret, Benjamin; Kerjouan, Mallorie; Michels, Sebastian; Pall, Georg; Rothschild, Sacha; Schmid-Bindert, Gerald; Scheffler, Matthias; Veillon, Rémi; Wannesson, Luciano; Diebold, Joachim; Zalcman, Gérard; Filleron, Thomas; Mazières, Julien (2015). Targeted therapy for patients with BRAF-mutant lung cancer: results from the european EURAF cohort. Journal of Thoracic Oncology, 10(10):1451-1457.

Bock, Thomas

Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasits, Ulrich; Gundry, Rebekah L; Yoon, Charles; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Härtlová, Anetta; Van Eyk, Jennifer E; Bourquin, Jean-Pierre; Aebersold, Ruedi; Boheler, Kenneth R; Zandstra, Peter; Wollscheid, Bernd (2015). A mass spectrometric-derived cell surface protein atlas. PLoS ONE, 10(3):e0121314.

Bockisch, A

Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Král, Z; Fuchs, M; Hallek, M; Kanz, L; Döhner, H; Dörken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, H T; Müller, R P; Dietlein, M; Borchmann, P; Diehl, V (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet, 379(9828):1791-1799.

Bode, B

Scharl, M; Bode, B; Rushing, E; Knuth, A; Rordorf, Tamara (2014). Uncommon case of brain metastasis in a patient with a history of heavy smoking. Current Oncology, 21:e728-731.

Sharma, A; Bode, B; Wenger, R H; Lehmann, K; Sartori, A A; Moch, H; Knuth, A; von Boehmer, L; van den Broek, Maries (2011). Gamma-radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS ONE, 6(11):e28217.

Stenner, F; Liewen, H; Zweifel, M; Weber, A; Tchinda, J; Bode, B; Samaras, P; Bauer, S; Knuth, A; Renner, C (2008). Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo. Cancer Science, 99(9):1847-1852.

Bode, Beata

Cathomas, Richard; Rothermundt, Christian; Bode, Beata; Fuchs, Bruno; von Moos, Roger; Schwitter, Michael (2015). RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward? Oncology, 88(4):257-260.

Sharma, Anu; Bode, Beata; Moch, Holger; Okoniewski, Michal; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2013). Radiotherapy of human sarcoma promotes an intratumoral immune effector signature. Clinical Cancer Research, 19(17):4843-4853.

Sharma, Anu; Bode, Beata; Wenger, Roland H; Lehmann, Kuno; Sartori, Alessandro A; Moch, Holger; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2011). γ-radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS ONE, 6(11):e28217.

Bode, P K

Fankhauser, C D; Curioni-Fontecedro, A; Allmann, V; Beyer, J; Tischler, V; Sulser, T; Moch, H; Bode, P K (2015). Frequent PD-L1 expression in testicular germ cell tumors. British Journal of Cancer, 113(3):411-413.

Bode, Peter

Thalhammer, Verena; Lopez-Garcia, Laura A; Herrero Martin, David; Hecker, Regina; Laubscher, Dominik; Gierisch, Maria E; Wachtel, Marco; Bode, Peter; Nanni, Paolo; Blank, Bernd; Koscielniak, Ewa; Schäfer, Beat W (2015). PLK1 phosphorylates PAX3-FOXO1 the inhibition of which triggers regression of alveolar rhabdomyosarcoma. Cancer Research, 75(1):98-110.

von Boehmer, Lotta; Mattle, Muriel; Bode, Peter; Landshammer, Alexandro; Schäfer, Carolin; Nuber, Natko; Ritter, Gerd; Old, Lloyd; Moch, Holger; Schäfer, Niklaus; Jäger, Elke; Knuth, Alexander; van den Broek, Maries (2013). NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma. Cancer Immunity, 13:12.

Bode, Peter K

Fankhauser, Christian D; Bode, Peter K; Hermanns, Thomas; Sander, Sophia; Beyer, Joerg; Sulser, Tullio; Altevogt, Peter; Moch, Holger; Tischler, Verena (2016). L1-CAM is commonly expressed in testicular germ cell tumours. Journal of Clinical Pathology, 69(5):460-462.

Bodis, S

Ribi, K; Bernhard, J; Schuller, J C; Weder, W; Bodis, S; Jörger, M; Betticher, D; Schmid, R A; Stupp, R; Ris, H B; Stahel, R A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer, 61(3):398-404.

Bodla, Shankar

Seifert, Heike; Georgiou, Alexandros; Alexander, Helen; McLachlan, Jennifer; Bodla, Shankar; Kaye, Stan; Barton, Desmond; Nobbenhuis, Marielle; Gore, Martin; Banerjee, Susana (2015). Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). Gynecologic Oncology, 139(2):216-220.

Bodoky, G

Koeberle, D; Dufour, J-F; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Buehlmann, M; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer Research (SAKK) (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of Oncology, 27(5):856-861.

Bernhard, J; Dietrich, D; Scheithauer, W; Gerber, D; Bodoky, G; Ruhstaller, T; Glimelius, B; Bajetta, E; Schüller, J; Saletti, P; Bauer, J; Figer, A; Pestalozzi, B C; Köhne, C H; Mingrone, W; Stemmer, S M; Tàmas, K; Kornek, G V; Koeberle, D; Herrmann, R (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial - SAKK 44/00-CECOG/PAN.1.3.001. Journal of Clinical Oncology, 26(22):3695-3701.

Body, J

Body, J; Henry, D; von Moos, R; Rider, A; De Courcy, J; Murray, G; Bhowmik, D; Gatta, F; Arellano, J; Hechmati, G; Qian, Y (2015). Bone pain and bone targeting agent (Bta) treatment pattern in patients with bone metastases (Bms) from prostate cancer (Pc) in real world setting in Europe. Value in Health, 18(7):A493.

Body, Jean-Jacques

Body, Jean-Jacques; Pereira, João; Sleeboom, Harm; Maniadakis, Nikos; Terpos, Evangelos; Acklin, Yves Pascal; Finek, Jindrich; Gunther, Oliver; Hechmati, Guy; Mossman, Tony; Costa, Luis; Rogowski, Wojciech; Nahi, Hareth; von Moos, Roger (2016). Health resource utilization associated with skeletal-related events: results from a retrospective European study. European Journal of Health Economics, 17(6):711-721.

von Moos, Roger; Body, Jean-Jacques; Egerdie, Blair; Stopeck, Alison; Brown, Janet; Fallowfield, Lesley; Patrick, Donald L; Cleeland, Charles; Damyanov, Danail; Palazzo, Felipe Salvador; Marx, Gavin; Zhou, Ying; Braun, Ada; Balakumaran, Arun; Qian, Yi (2016). Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer, 24(3):1327-1337.

Diel, Ingo J; Body, Jean-Jacques; Stopeck, Alison T; Vadhan-Raj, Saroj; Spencer, Andrew; Steger, Günther; von Moos, Roger; Goldwasser, François; Feng, Amy; Braun, Ada (2015). The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. European Journal of Cancer, 51(11):1467-1475.

Boehler, Annette

von Boehmer, Lotta; Draenert, Alice; Jungraithmayr, Wolfgang; Inci, Ilhan; Niklaus, Schäfer; Boehler, Annette; Hofer, Markus; Stahel, Rolf; Soltermann, Alex; van den Broek, Maries; Weder, Walter; Knuth, Alexander (2012). Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer, 76(1):118-122.

Boehlke, Ina

Berger, Lars A; Bokemeyer, Carsten; Lorch, Anja; Hentrich, Marcus; Kopp, Hans‑Georg; Gauler, Thomas C; Beyer, Jörg; de Wit, Maike; Mayer, Frank; Boehlke, Ina; Oing, Christoph; Honecker, Friedemann; Oechsle, Karin (2014). First salvage treatment in patients with advanced germ cell cancer after cisplatin‑based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Journal of Cancer Research and Clinical Oncology, 140(7):1211-1220.

Bogaerts, J

Stahel, R; Bogaerts, J; Ciardiello, F; de Ruysscher, D; Dubsky, P; Ducreux, M; Finn, S; Laurent-Puig, P; Peters, S; Piccart, M; Smit, E; Sotiriou, C; Tejpar, S; Van Cutsem, E; Tabernero, J (2015). Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development. Cancer Treatment Reviews, 41(2):129-135.

Bogaerts, Jan

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi; De Santis, Maria; de Vries, Elisabeth G E; Dizon, Don S; Duff, Jennifer; Duska, Linda R; Eniu, Alexandru; et al (2016). ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 1(5):e000097.

Bogaertsa, Jan

Lacombea, Denis; Burocka, Susen; Bogaertsa, Jan; Schoeffskib, Patrick; Golfinopoulosa, Vassilis; Stupp, Roger (2014). The dream and reality of histology agnostic cancer clinical trials. Molecular Oncology, 8(6):1057-1063.

Bohanes, P

Winder, T; Giamas, G; Wilson, P M; Zhang, W; Bohanes, P; Ning, Y; Gerger, A; Stebbing, J; Lenz, H-J (2014). Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients Q1 treated with tamoxifen. Pharmacogenomics Journal, 14:28-34.

Boheler, Kenneth R

Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasits, Ulrich; Gundry, Rebekah L; Yoon, Charles; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Härtlová, Anetta; Van Eyk, Jennifer E; Bourquin, Jean-Pierre; Aebersold, Ruedi; Boheler, Kenneth R; Zandstra, Peter; Wollscheid, Bernd (2015). A mass spectrometric-derived cell surface protein atlas. PLoS ONE, 10(3):e0121314.

Bohnert, A

Rechsteiner, M; Wild, P; Kiessling, M K; Bohnert, A; Zhong, Q; Stahel, R A; Moch, H; Curioni-Fontecedro, A (2015). A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib. Annals of Oncology, 26(1):246-248.

Bokemeyer, C

Schwab, M; Zanger, U M; Marx, C; Schaeffeler, E; Klein, K; Dippon, J; Kerb, R; Blievernicht, J; Fischer, J; Hofmann, U; Bokemeyer, C; Eichelbaum, M (2008). Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group. Journal of Clinical Oncology, 26(13):2131-2138.

Al-Batran, S E; Hartmann, J T; Probst, S; Schmalenberg, H; Hollerbach, S; Hofheinz, R; Rethwisch, V; Seipelt, G; Homann, N; Wilhelm, G; Schuch, G; Stoehlmacher, J; Derigs, H G; Hegewisch-Becker, S; Grossmann, J; Pauligk, C; Atmaca, A; Bokemeyer, C; Knuth, A; Jäger, E (2008). Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. Journal of Clinical Oncology, 26(9):1435-1442.

Bokemeyer, Carsten

Feldman, Darren R; Lorch, Anja; Kramar, Andrew; Albany, Costantine; Einhorn, Lawrence H; Giannatempo, Patrizia; Necchi, Andrea; Flechon, Aude; Boyle, Helen; Chung, Peter; Huddart, Robert A; Bokemeyer, Carsten; Tryakin, Alexey; Sava, Teodoro; Winquist, Eric William; De Giorgi, Ugo; Aparicio, Jorge; Sweeney, Christopher J; Cohn Cedermark, Gabriella; Beyer, Jörg; Powles, Thomas (2016). Brain metastases in patients with germ cell tumors: prognostic factors and treatment options: an analysis from the global germ cell cancer group. Journal of Clinical Oncology, 34(4):345-351.

Oing, Christoph; Lorch, Anja; Bokemeyer, Carsten; Honecker, Friedemann; Beyer, Jörg; Berger, Lars Arne; Oechsle, Karin (2015). First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database. Journal of Cancer Research and Clinical Oncology, 141(5):923-931.

Berger, Lars A; Bokemeyer, Carsten; Lorch, Anja; Hentrich, Marcus; Kopp, Hans‑Georg; Gauler, Thomas C; Beyer, Jörg; de Wit, Maike; Mayer, Frank; Boehlke, Ina; Oing, Christoph; Honecker, Friedemann; Oechsle, Karin (2014). First salvage treatment in patients with advanced germ cell cancer after cisplatin‑based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Journal of Cancer Research and Clinical Oncology, 140(7):1211-1220.

Bolliger, M F

Bolliger, M F; Zurlinden, A; Lüscher, D; Bütikofer, L; Shakhova, O; Francolini, M; Kozlov, S V; Cinelli, P; Stephan, A; Kistler, A D; Rülicke, T; Pelczar, P; Ledermann, B; Fumagalli, G; Gloor, S M; Kunz, B; Sonderegger, P (2010). Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. Journal of Cell Science, 123(Pt 22):3944-3955.

Bonalli, Mario

Zingg, Daniel; Debbache, Julien; Schaefer, Simon M; Tuncer, Eylul; Frommel, Sandra C; Cheng, Phil; Arenas-Ramirez, Natalia; Haeusel, Jessica; Zhang, Yudong; Bonalli, Mario; McCabe, Michael T; Creasy, Caretha L; Levesque, Mitchell P; Boyman, Onur; Santoro, Raffaella; Shakhova, Olga; Dummer, Reinhard; Sommer, Lukas (2015). The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nature Communications, 6:6051.

Boone, D L

Scharl, M; Wojtal, K A; Becker, H M; Fischbeck, A; Frei, P; Arikkat, J; Pesch, T; Kellermeier, S; Boone, D L; Weber, A; Loessner, M J; Vavricka, S R; Fried, M; McCole, D F; Rogler, G (2012). Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflammatory Bowel Diseases, 18(7):1287-1302.

Borchers, Christian

Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; Bromberg, Jacoline E C; Mason, Warren P; Hoang-Xuan, Khê; Ryan, Gail; Hassel, Mohamed Ben; Enting, Roelien H; Brandes, Alba A; Wick, Antje; Chinot, Olivier; Reni, Michele; Kantor, Guy; Thiessen, Brian; Klein, Martin; Verger, Eugenie; Borchers, Christian; Hau, Peter; Back, Michael; Smits, Anja; Golfinopoulos, Vassilis; Gorlia, Thierry; Bottomley, Andrew; Stupp, Roger; Baumert, Brigitta G (2016). Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1533-1542.

Borchmann, P

Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Král, Z; Fuchs, M; Hallek, M; Kanz, L; Döhner, H; Dörken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, H T; Müller, R P; Dietlein, M; Borchmann, P; Diehl, V (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet, 379(9828):1791-1799.

Bordoni, Andrea

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri; Szucs, Thomas; Pestalozzi, Bernhard C; Schwenkglenks, Matthias (2015). Cancer-related therapies at the end of life in hospitalized cancer patients from four swiss cantons: SAKK 89/09. Oncology, 88(1):18-27.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons a retrospective database study (SAKK 89/09). BMC Cancer, 14:306.

Borner, M

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollar, A; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V; Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26(4):709-714.

Borner, M; Koeberle, D; Von Moos, R; Saletti, P; Rauch, D; Hess, V; Trojan, A; Helbling, D; Pestalozzi, B; Caspar, Christian; Ruhstaller, T; Roth, A; Kappeler, A; Dietrich, D; Lanz, D; Mingrone, W (2008). Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the swiss group for clinical cancer research SAKK. Annals of Oncology, 19(7):1288 -1292 .

Borner, Markus

Kasenda, Benjamin; Bass, Annatina; Koeberle, Dieter; Pestalozzi, Bernhard; Borner, Markus; Herrmann, Richard; Jost, Lorenz; Lohri, Andreas; Hess, Viviane (2014). Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer, 14:728.

Borst, J

Keller, A M; Schildknecht, A; Xiao, Y; van den Broek, M; Borst, J (2008). Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity. Immunity, 29(6):934-946.

Boss, Andreas

Meerang, Mayura; Bérard, Karima; Felley-Bosco, Emanuela; Lauk, Olivia; Vrugt, Bart; Boss, Andreas; Kenkel, David; Broggini-Tenzer, Angela; Stahel, Rolf A; Arni, Stephan; Weder, Walter; Opitz, Isabelle (2016). Antagonizing the hedgehog pathway with vismodegib impairs malignant pleural mesothelioma growth in vivo by affecting stroma. Molecular Cancer Therapeutics, 15(5):1095-1105.

Bossart, W

Curioni-Fontecedro, A; Knights, A J; Tinguely, M; Nuber, N; Schneider, C; Thomson, C W; von Boehmer, I; Bossart, W; Pahlich, S; Gehring, H; Moch, H; Renner, C; Knuth, A; Zippelius, A (2008). MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma. Leukemia, 22(8):1646-1648.

Bosshard, G

Soldini, D; Montagna, C; Schüffler, P; Martin, V; Georgis, A; Thiesler, T; Curioni-Fontecedro, A; Went, P; Bosshard, G; Dehler, Silvia; Mazzuchelli, L; Tinguely, M (2013). A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. Annals of Oncology, 24(1):193-201.

Bottomley, Andrew

Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; Bromberg, Jacoline E C; Mason, Warren P; Hoang-Xuan, Khê; Ryan, Gail; Hassel, Mohamed Ben; Enting, Roelien H; Brandes, Alba A; Wick, Antje; Chinot, Olivier; Reni, Michele; Kantor, Guy; Thiessen, Brian; Klein, Martin; Verger, Eugenie; Borchers, Christian; Hau, Peter; Back, Michael; Smits, Anja; Golfinopoulos, Vassilis; Gorlia, Thierry; Bottomley, Andrew; Stupp, Roger; Baumert, Brigitta G (2016). Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1533-1542.

Zikos, Efstathios; Ghislain, Irina; Coens, Corneel; Ediebah, Divine E; Sloan, Elizabeth; Quinten, Chantal; Koller, Michael; van Meerbeeck, Jan P; Flechtner, Hans-Henning; Stupp, Roger; Czimbalmos, Agnes; Sprangers, Mirjam A G; Bottomley, Andrew (2014). Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials. Lancet Oncology, 15(2):e78-e89.

Botton, Alessandro

Vegro, Mara; Eccher, Giulia; Populin, Francesca; Sorgato, Chiara; Savazzini, Federica; Pagliarani, Giulia; Tartarini, Stefano; Pasini, Gabriella; Curioni, Andrea; Antico, Andrea; Botton, Alessandro (2016). Old apple (malus domestica L. Borkh) varieties with hypoallergenic properties: an integrated approach for studying apple allergenicity. Journal of Agricultural and Food Chemistry, 64(48):9224-9236.

Bouabdallah, K

Renner, C; Zinzani, P L; Gressin, R; Klingbiel, D; Dietrich, P Y; Hitz, P; Bargetzi, M; Mingrone, W; Martinelli, G; Trojan, A; Bouabdallah, K; Lohri, A; Gyan, E; Biaggi, C; Cogliatti, S; Bertoni, F; Ghielmini, M; Brauchli, P; Ketterer, N (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica, 97(7):1085-1091.

Bouchal, Jan

Gachechiladze, Mariam; Škarda, Josef; Kolek, Vítězslav; Grygárková, Ivona; Langová, Kateřina; Bouchal, Jan; Kolář, Zdeněk; Baty, Florent; Stahel, Rolf; Weder, Walter; Soltermann, Alex; Joerger, Markus (2017). Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer, 105:31-38.

Boumendil, A

Meissner, J; Finel, H; Dietrich, S; Boumendil, A; Kanfer, E; Laboure, G; Abecasis, M; Cornelissen, J; Delage, J; Finke, J; Hess, U; Ludwig, H; Mohty, M; Pabst, T; Pioltelli, P; Robinson, S; Samaras, P; Montoto, S; Dreger, P (2017). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone Marrow Transplantation, 52(4):650-652.

Bourquin, Jean-Pierre

Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasits, Ulrich; Gundry, Rebekah L; Yoon, Charles; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Härtlová, Anetta; Van Eyk, Jennifer E; Bourquin, Jean-Pierre; Aebersold, Ruedi; Boheler, Kenneth R; Zandstra, Peter; Wollscheid, Bernd (2015). A mass spectrometric-derived cell surface protein atlas. PLoS ONE, 10(3):e0121314.

Pfrommer, Sarah; Weber, Achim; Dutkowski, Philipp; Schäfer, Niklaus G; Müllhaupt, Beat; Bourquin, Jean-Pierre; Breitenstein, Stefan; Pestalozzi, Bernhard C; Stenner, Frank; Renner, Christoph; D'Addario, Giannicola; Graf, Hans-Jörg; Knuth, Alexander; Clavien, Pierre-Alain; Samaras, Panagiotis (2013). Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the pancreas in an adolescent patient. Case Reports in Oncology, 6(3):497-503.

Bouton, M C

Maciejewska Rodrigues, H; Al-Shamisi, M; Hemmatazad, H; Ospelt, C; Bouton, M C; Jäger, D; Cope, A P; Charles, P; Plant, D; Distler, J H W; Gay, R E; Michel, B A; Knuth, A; Neidhart, M; Gay, S; Jüngel, A (2010). Functional autoantibodies against serpin E2 in rheumatoid arthritis. Arthritis and Rheumatism, 62(1):93-104.

Bowness, P

Payeli, S K; Kollnberger, S; Marroquin Belaunzaran, O; Thiel, M; McHugh, K; Giles, J; Shaw, J; Kleber, S; Ridley, A; Wong-Baeza, I; Keidel, S; Kuroki, K; Maenaka, K; Wadle, A; Renner, C; Bowness, P (2012). Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis. Arthritis & Rheumatism, 64(10):3139-3149.

Bowness, Paul

McHugh, Kirsty; Rysnik, Oliwia; Kollnberger, Simon; Shaw, Jacqueline; Utriainen, Lotta; Al-Mossawi, Mohammad Hussein; Payeli, Sravan; Marroquin, Osiris; Milling, Simon; Renner, Christoph; Bowness, Paul (2014). Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply. Annals of the Rheumatic Diseases, 73(4):763-770.

Boyle, Helen

Feldman, Darren R; Lorch, Anja; Kramar, Andrew; Albany, Costantine; Einhorn, Lawrence H; Giannatempo, Patrizia; Necchi, Andrea; Flechon, Aude; Boyle, Helen; Chung, Peter; Huddart, Robert A; Bokemeyer, Carsten; Tryakin, Alexey; Sava, Teodoro; Winquist, Eric William; De Giorgi, Ugo; Aparicio, Jorge; Sweeney, Christopher J; Cohn Cedermark, Gabriella; Beyer, Jörg; Powles, Thomas (2016). Brain metastases in patients with germ cell tumors: prognostic factors and treatment options: an analysis from the global germ cell cancer group. Journal of Clinical Oncology, 34(4):345-351.

Boyman, Onur

Zingg, Daniel; Debbache, Julien; Schaefer, Simon M; Tuncer, Eylul; Frommel, Sandra C; Cheng, Phil; Arenas-Ramirez, Natalia; Haeusel, Jessica; Zhang, Yudong; Bonalli, Mario; McCabe, Michael T; Creasy, Caretha L; Levesque, Mitchell P; Boyman, Onur; Santoro, Raffaella; Shakhova, Olga; Dummer, Reinhard; Sommer, Lukas (2015). The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nature Communications, 6:6051.

Brada, Michael

Weller, Michael; Wick, Wolfgang; Aldape, Ken; Brada, Michael; Berger, Mitchell; Pfister, Stefan M; Nishikawa, Ryo; Rosenthal, Mark; Wen, Patrick Y; Stupp, Roger; Reifenberger, Guido (2015). Glioma. Nature Reviews. Disease Primers, (2015):15017.

Brambilla, Elisabeth

Stahel, Rolf; Peters, Solange; Baas, Paul; Brambilla, Elisabeth; Cappuzzo, Federico; De Ruysscher, Dirk; Eberhardt, Wilfried Ernst Erich; Felip, Enriqueta; Fennell, Dean; Marchetti, Antonio; Paz-Ares, Luis; Adjei, Alex A (2013). Strategies for improving outcomes in NSCLC: a look to the future. Lung Cancer, 82(3):375-382.

Brand, K

Karbach, J; Neumann, A; Atmaca, A; Wahle, C; Brand, K; von Boehmer, L; Knuth, A; Bender, A; Ritter, G; Old, L J; Jäger, E (2011). Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients. Clinical Cancer Research, 17(4):861-870.

Brandes, Alba A

Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; Bromberg, Jacoline E C; Mason, Warren P; Hoang-Xuan, Khê; Ryan, Gail; Hassel, Mohamed Ben; Enting, Roelien H; Brandes, Alba A; Wick, Antje; Chinot, Olivier; Reni, Michele; Kantor, Guy; Thiessen, Brian; Klein, Martin; Verger, Eugenie; Borchers, Christian; Hau, Peter; Back, Michael; Smits, Anja; Golfinopoulos, Vassilis; Gorlia, Thierry; Bottomley, Andrew; Stupp, Roger; Baumert, Brigitta G (2016). Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1533-1542.

Baumert, Brigitta G; Hegi, Monika E; van den Bent, Martin J; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khê; Brandes, Alba A; Kantor, Guy; Taphoorn, Martin J B; Hassel, Mohamed Ben; Hartmann, Christian; Ryan, Gail; Capper, David; Kros, Johan M; Kurscheid, Sebastian; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline E; Feuvret, Loic; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Johanna M M; Rossiter, John P; Dif, Nicolas; Balana, Carmen; Bravo-Marques, Jose; Clement, Paul M; et al (2016). Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1521-1532.

Wick, Wolfgang; Gorlia, Thierry; Bady, Pierre; Platten, Michael; van den Bent, Martin J; Taphoorn, Martin J B; Steuve, Jonathan; Brandes, Alba A; Hamou, Marie-France; Wick, Antje; Kosch, Markus; Weller, Michael; Stupp, Roger; Roth, Patrick; Golfinopoulos, Vassilis; Frenel, Jean-Sebastien; Campone, Mario; Ricard, Damien; Marosi, Christine; Villà, Salvador; Weyerbrock, Astrid; Hopkins, Kirsten; Homicsko, Krisztian; Lhermitte, Benoit; Pesce, Gianfranco Angelo; Hegi, Monika E (2016). Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research, 22(19):4797-4806.

Brandt, Simone

Brandt, Simone; Montagna, Chiara; Georgis, Antoin; Schüffler, Peter J; Bühler, Marco M; Seifert, Burkhardt; Thiesler, Thore; Curioni-Fontecedro, Alessandra; Hegyi, Ivan; Dehler, Silvia; Martin, Vittoria; Tinguely, Marianne; Soldini, Davide (2013). The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Experimental Hematology & Oncology, 2:27.

Brauchli, P

Pagani, O; Klingbiel, D; Ruhstaller, T; Nolè, F; Eppenberger, S; Oehlschlegel, C; Bernhard, J; Brauchli, P; Hess, D; Mamot, C; Munzone, E; Pestalozzi, B; Rabaglio, M; Aebi, S; Ribi, K; Rochlitz, C; Rothgiesser, K; Thürlimann, B; Moos, R von; Zaman, K; Goldhirsch, A; Swiss Group for Clinical Cancer Research (SAKK) (2017). Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized Phase III trial SAKK 22/99. Annals of Oncology, 28(2):305-312.

Strasser, F; Blum, D; von Moos, R; Cathomas, R; Ribi, K; Aebi, S; Betticher, D; Hayoz, S; Klingbiel, D; Brauchli, P; Haefner, M; Mauri, S; Kaasa, S; Koeberle, D (2016). The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Annals of Oncology, 27(2):324-332.

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollar, A; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V; Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26(4):709-714.

Joerger, M; Baty, F; Früh, M; Droege, C; Stahel, R A; Betticher, D C; von Moos, R; Ochsenbein, A; Pless, M; Gautschi, O; Rothschild, S; Brauchli, P; Klingbiel, D; Zappa, F; Brutsche, M (2014). Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer, 85(2):306-313.

Zappa, F; Droege, C; Betticher, D; von Moos, R; Bubendorf, L; Ochsenbein, A; Gautschi, O; Oppliger Leibundgut, E; Froesch, P; Stahel, R; Hess, T; Rauch, D; Schmid, P; Mayer, M; Crowe, S; Brauchli, P; Ribi, K; Pless, M (2012). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05). Lung Cancer, 78(3):239-244.

Renner, C; Zinzani, P L; Gressin, R; Klingbiel, D; Dietrich, P Y; Hitz, P; Bargetzi, M; Mingrone, W; Martinelli, G; Trojan, A; Bouabdallah, K; Lohri, A; Gyan, E; Biaggi, C; Cogliatti, S; Bertoni, F; Ghielmini, M; Brauchli, P; Ketterer, N (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica, 97(7):1085-1091.

Brauchli, Peter

Hayoz, Stefanie; Klingbiel, Dirk; Brauchli, Peter; von Moos, Roger (2013). What can we learn from the ZOOM trial? Lancet Oncology, 14(10):e388.

Brauer, Sabine

Schildknecht, Anita; Brauer, Sabine; Brenner, Corinne; Lahl, Katharina; Schild, Hansjörg; Sparwasser, Tim; Probst, Hans C; van den Broek, Maries (2010). FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 107(1):199-203.

Braun, Ada

von Moos, Roger; Body, Jean-Jacques; Egerdie, Blair; Stopeck, Alison; Brown, Janet; Fallowfield, Lesley; Patrick, Donald L; Cleeland, Charles; Damyanov, Danail; Palazzo, Felipe Salvador; Marx, Gavin; Zhou, Ying; Braun, Ada; Balakumaran, Arun; Qian, Yi (2016). Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer, 24(3):1327-1337.

Diel, Ingo J; Body, Jean-Jacques; Stopeck, Alison T; Vadhan-Raj, Saroj; Spencer, Andrew; Steger, Günther; von Moos, Roger; Goldwasser, François; Feng, Amy; Braun, Ada (2015). The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. European Journal of Cancer, 51(11):1467-1475.

Braun, R

Matter-Walstra, K; Braun, R; Kolb, C; Ademi, Z; Dummer, R; Pestalozzi, B C; Schwenkglenks, M (2015). A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting. British Journal of Dermatology, 173(6):1462-1470.

Braun, S

Braun, S; Oppermann, H; Mueller, A; Renner, C; Hovhannisyan, A; Baran-Schmidt, R; Gebhardt, R; Hipkiss, A; Thiery, J; Meixensberger, J; Gaunitz, F (2012). Hedgehog signaling in glioblastoma multiforme. Cancer Biology & Therapy, 13(7):487-495.

Bravo-Marques, Jose

Baumert, Brigitta G; Hegi, Monika E; van den Bent, Martin J; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khê; Brandes, Alba A; Kantor, Guy; Taphoorn, Martin J B; Hassel, Mohamed Ben; Hartmann, Christian; Ryan, Gail; Capper, David; Kros, Johan M; Kurscheid, Sebastian; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline E; Feuvret, Loic; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Johanna M M; Rossiter, John P; Dif, Nicolas; Balana, Carmen; Bravo-Marques, Jose; Clement, Paul M; et al (2016). Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1521-1532.

Braziulis, E

Fischer, E; Kobold, S; Kleber, S; Kubuschok, B; Braziulis, E; Knuth, A; Renner, C; Wadle, A (2010). Cryptic epitopes induce high-titer humoral immune response in patients with cancer. Journal of Immunology, 85(5):3095-3102.

Bredell, M

Studer, G; Brown, M; Bredell, M; Graetz, K W; Huber, G; Linsenmeier, C; Najafi, Y; Riesterer, O; Rordorf, T; Schmid, S; Glanzmann, C (2012). Follow up after IMRT in oral cavity cancer: update. Radiation Oncology, 7:84.

Bredell, Marius

Brown, Michelle L; Glanzmann, Christoph; Huber, Gerhard; Bredell, Marius; Rordorf, Tamara; Studer, Gabriela (2016). IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80. Strahlentherapie und Onkologie, 192(8):526-536.

Bredell, Marius G

Ernst, Jutta; Ikenberg, Kristian; Apel, Barbara; Schumann, Desiree M; Huber, Gerhard; Studer, Gabriela; Rordorf, Tamara; Riesterer, Oliver; Rössle, Matthias; Korol, Dimitri; Bredell, Marius G (2016). Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue. OncoTarget, 7(46):76151-76158.

Breitenstein, S

Samaras, P; Breitenstein, S; Haile, S R; Stenner-Liewen, F; Heinrich, S; Feilchenfeldt, J; Renner, C; Knuth, A; Pestalozzi, B C; Clavien, P A (2011). Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases. Annals of Surgical Oncology, 18(7):1924-1931.

Riener, M O; Stenner, F; Liewen, H; Soll, C; Breitenstein, S; Pestalozzi, B C; Samaras, P; Probst-Hensch, N M; Hellerbrand, C; Müllhaupt, B; Clavien, P A; Bahra, M; Neuhaus, P; Wild, P; Fritzsche, F; Moch, H; Jochum, W; Kristiansen, G (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49(5):1602 -1609.

Breitenstein, Stefan

Pfrommer, Sarah; Weber, Achim; Dutkowski, Philipp; Schäfer, Niklaus G; Müllhaupt, Beat; Bourquin, Jean-Pierre; Breitenstein, Stefan; Pestalozzi, Bernhard C; Stenner, Frank; Renner, Christoph; D'Addario, Giannicola; Graf, Hans-Jörg; Knuth, Alexander; Clavien, Pierre-Alain; Samaras, Panagiotis (2013). Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the pancreas in an adolescent patient. Case Reports in Oncology, 6(3):497-503.

Brenner, Corinne

Schildknecht, Anita; Brauer, Sabine; Brenner, Corinne; Lahl, Katharina; Schild, Hansjörg; Sparwasser, Tim; Probst, Hans C; van den Broek, Maries (2010). FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 107(1):199-203.

Schildknecht, Anita; Probst, Hans C; McCoy, Kathy D; Miescher, Iris; Brenner, Corinne; Leone, Dino P; Suter, Ueli; Ohashi, Pamela S; van den Broek, Maries (2009). Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells. European Journal of Immunology, 36(6):1505-1515.

Brentano, F

Ospelt, C; Mertens, J C; Jüngel, A; Brentano, F; Maciejewska Rodrigues, H; Huber, L C; Hemmatazad, H; Wüest, T; Knuth, A; Gay, R E; Michel, B A; Gay, S; Renner, C; Bauer, S (2010). Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 62(5):1224-1235.

Britschgi, Adrian

Jenal, Mathias; Trinh, Emmanuelle; Britschgi, Christian; Britschgi, Adrian; Roh, Vincent; Vorburger, Stephan A; Tobler, Andreas; Leprince, Dominique; Fey, Martin F; Helin, Kristian; Tschan, Mario P (2009). The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Molecular Cancer Research, 7(6):916-922.

Britschgi, Christian

Lipinski, Kamil Andrzej; Britschgi, Christian; Schrader, Karen; Christinat, Yann; Frischknecht, Lukas; Krek, Wilhelm (2016). Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1. OncoTarget, 7(20):29635-29647.

Tschan, Mario P; Federzoni, Elena A; Haimovici, Aladin; Britschgi, Christian; Moser, Bettina A; Jin, Jing; Reddy, Venkateshwar A; Sheeter, Dennis A; Fischer, Kimberlee M; Sun, Peiqing; Torbett, Bruce E (2015). Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation. BBA - Biochimica et Biophysica Acta, 1849(9):1198-1208.

Jenal, Mathias; Trinh, Emmanuelle; Britschgi, Christian; Britschgi, Adrian; Roh, Vincent; Vorburger, Stephan A; Tobler, Andreas; Leprince, Dominique; Fey, Martin F; Helin, Kristian; Tschan, Mario P (2009). The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Molecular Cancer Research, 7(6):916-922.

Broaddus, V C

Echeverry, N; Ziltener, G; Barbone, D; Weder, W; Stahel, R A; Broaddus, V C; Felley-Bosco, E (2015). Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death and Disease, 6:e1757.

Brodowicz, T

Brodowicz, T; Ciuleanu, T; Crawford, J; Filipits, M; Fischer, J R; Georgoulias, V; Gridelli, C; Hirsch, F R; Jassem, J; Kosmidis, P; Krzakowski, M; Manegold, C; Pujol, J L; Stahel, R; Thatcher, N; Vansteenkiste, J; Minichsdorfer, C; Zöchbauer-Müller, S; Pirker, R; Zielinski, C C (2012). Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. Annals of Oncology, 23(5):1223-1229.

Broek, M

Flatz, L; Hegazy, A N; Bergthaler, A; Verschoor, A; Claus, C; Fernandez-Rivas, M; Gattinoni, L; Johnson, S; Kreppel, F; Kochanek, S; Broek, M; Radbruch, A; Lévy, F; Lambert, P H; Siegrist, C A; Restifo, N P; Löhning, M; Ochsenbein, A F; Nabel, G J; Pinschewer, D D (2010). Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nature Medicine, 16(3):339-345.

Broggini-Tenzer, A

Oehler, C; Frei, K; Rushin, E J; McSheehy, P M J; Weber, D; Allegrini, P R; Weniger, D; Lütolf, U M; Knuth, A; Yonekawa, Y; Barath, K; Broggini-Tenzer, A; Pruschy, M; Hofer, S (2012). Patupilone (Epothilone B) for recurrent glioblastoma: Clinical outcome and translational analysis of a single-institution phase I/II trial. Oncology, 83(1):1-9.

Broggini-Tenzer, Angela

Meerang, Mayura; Bérard, Karima; Felley-Bosco, Emanuela; Lauk, Olivia; Vrugt, Bart; Boss, Andreas; Kenkel, David; Broggini-Tenzer, Angela; Stahel, Rolf A; Arni, Stephan; Weder, Walter; Opitz, Isabelle (2016). Antagonizing the hedgehog pathway with vismodegib impairs malignant pleural mesothelioma growth in vivo by affecting stroma. Molecular Cancer Therapeutics, 15(5):1095-1105.

Brokopp, C E

Brokopp, C E; Schoenauer, R; Richards, P; Bauer, S; Lohmann, C; Emmert, M Y; Weber, B; Winnik, S; Aikawa, E; Graves, K; Genoni, M; Vogt, P; Luscher, T F; Renner, C; Hoerstrup, S P; Matter, C M (2011). Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. European Heart Journal, 32(21):2713-2722.

Bromberg, Jacoline E

Baumert, Brigitta G; Hegi, Monika E; van den Bent, Martin J; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khê; Brandes, Alba A; Kantor, Guy; Taphoorn, Martin J B; Hassel, Mohamed Ben; Hartmann, Christian; Ryan, Gail; Capper, David; Kros, Johan M; Kurscheid, Sebastian; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline E; Feuvret, Loic; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Johanna M M; Rossiter, John P; Dif, Nicolas; Balana, Carmen; Bravo-Marques, Jose; Clement, Paul M; et al (2016). Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1521-1532.

Bromberg, Jacoline E C

Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; Bromberg, Jacoline E C; Mason, Warren P; Hoang-Xuan, Khê; Ryan, Gail; Hassel, Mohamed Ben; Enting, Roelien H; Brandes, Alba A; Wick, Antje; Chinot, Olivier; Reni, Michele; Kantor, Guy; Thiessen, Brian; Klein, Martin; Verger, Eugenie; Borchers, Christian; Hau, Peter; Back, Michael; Smits, Anja; Golfinopoulos, Vassilis; Gorlia, Thierry; Bottomley, Andrew; Stupp, Roger; Baumert, Brigitta G (2016). Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 17(11):1533-1542.

Brossart, Peter

Volk, Viktoria; Cathomas, Richard; Mark, Michael; von Moos, Roger; Klingbiel, Dirk; Brossart, Peter; Mey, Ulrich (2016). Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience. Supportive Care in Cancer, 24(5):2119-2128.

Brown, Janet

von Moos, Roger; Body, Jean-Jacques; Egerdie, Blair; Stopeck, Alison; Brown, Janet; Fallowfield, Lesley; Patrick, Donald L; Cleeland, Charles; Damyanov, Danail; Palazzo, Felipe Salvador; Marx, Gavin; Zhou, Ying; Braun, Ada; Balakumaran, Arun; Qian, Yi (2016). Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer, 24(3):1327-1337.

Brown, M

Gulden-Sala, W; Roth, P; Brown, M; Andratschke, N; Weller, M; Stupp, R (2016). Gliome – was ich wissen muss in zehn Fragen. Praxis, 105(6):330-337.

Studer, G; Brown, M; Bredell, M; Graetz, K W; Huber, G; Linsenmeier, C; Najafi, Y; Riesterer, O; Rordorf, T; Schmid, S; Glanzmann, C (2012). Follow up after IMRT in oral cavity cancer: update. Radiation Oncology, 7:84.

Brown, Michelle L

Brown, Michelle L; Glanzmann, Christoph; Huber, Gerhard; Bredell, Marius; Rordorf, Tamara; Studer, Gabriela (2016). IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80. Strahlentherapie und Onkologie, 192(8):526-536.

Brown, Paul

Gorlia, Thierry; Wu, Wenting; Wang, Meihua; Baumert, Brigitta G; Mehta, Minesh; Buckner, Jan C; Shaw, Edward; Brown, Paul; Stupp, Roger; Galanis, Evanthia; Lacombe, Denis; van den Bent, Martin J (2013). New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro-Oncology, 15(11):1568-1579.

Brown, Paul D

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Brutsche, M

Joerger, M; Baty, F; Früh, M; Droege, C; Stahel, R A; Betticher, D C; von Moos, R; Ochsenbein, A; Pless, M; Gautschi, O; Rothschild, S; Brauchli, P; Klingbiel, D; Zappa, F; Brutsche, M (2014). Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer, 85(2):306-313.

Brutsche, Martin

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Gautschi, Oliver; Dingemans, Anne-Marie; Crowe, Susanne; Peters, Solange; Roder, Heinrich; Grigorieva, Julia; Roder, Joanna; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Baty, Florent; Bubendorf, Lukas; Hsu Schmitz, Shu-Fang; Na, Kyung-Jae; Carbone, David; Stahel, Rolf; Smit, Egbert (2013). VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer, 79(1):59-64.

Brügge, D

Hundsberger, T; Tonder, M; Hottinger, A; Brügge, D; Roelcke, U; Putora, P M; Stupp, R; Weller, M (2014). Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. Journal of Neuro-Oncology, 118(2):321-328.

Brüssow, Cornelia

Stieb, Sonja; Riesterer, Oliver; Brüssow, Cornelia; Pestalozzi, Bernhard C; Guckenberger, Matthias; Weiler, Stefan (2016). Radiation recall dermatitis induced by sorafenib : A case study and review of the literature. Strahlentherapie und Onkologie, 195(5):342-348.

Buac, Kristina

Harris, Melissa L; Buac, Kristina; Shakhova, Olga; Hakami, Ramin M; Wegner, Michael; Sommer, Lukas; Pavan, William J (2013). A dual role for Sox10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors. PLoS Genetics, 9(7):e1003644.

Bubendorf, L

Kerr, K M; Bubendorf, L; Edelman, M J; Marchetti, A; Mok, T; Novello, S; O'Byrne, K; Stahel, R; Peters, S; Felip, E (2014). Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Annals of Oncology, 25(9):1681-1690.

Zappa, F; Droege, C; Betticher, D; von Moos, R; Bubendorf, L; Ochsenbein, A; Gautschi, O; Oppliger Leibundgut, E; Froesch, P; Stahel, R; Hess, T; Rauch, D; Schmid, P; Mayer, M; Crowe, S; Brauchli, P; Ribi, K; Pless, M (2012). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05). Lung Cancer, 78(3):239-244.

D'Addario, G; Rauch, D; Stupp, R; Pless, M; Stahel, R; Mach, N; Jost, L; Widmer, L; Tapia, C; Bihl, M; Mayer, M; Ribi, K; Lerch, S; Bubendorf, L; Betticher, D C (2008). Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of Oncology, 19(4):739-745.

Bubendorf, Lukas

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Peters, Solange; Weder, Walter; Dafni, Urania; Kerr, Keith M; Bubendorf, Lukas; Meldgaard, Peter; O'Byrne, Kenneth J; Wrona, Anna; Vansteenkiste, Johan; Felip, Enriqueta; Marchetti, Antonio; Savic, Spasenija; Lu, Shun; Smit, Egbert; Dingemans, Anne-Marie; Blackhall, Fiona H; Baas, Paul; Camps, Carlos; Rosell, Rafael; Stahel, Rolf A (2014). Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. Journal of Thoracic Oncology, 9(11):1675-1684.

Blackhall, Fiona H; Peters, Solange; Bubendorf, Lukas; Dafni, Urania; Kerr, Keith M; Hager, Henrik; Soltermann, Alex; O'Byrne, Kenneth J; Dooms, Christoph; Sejda, Aleksandra; Hernández-Losa, Javier; Marchetti, Antonio; Savic, Spasenija; Tan, Qiang; Thunnissen, Erik; Speel, Ernst-Jan M; Cheney, Richard; Nonaka, Daisuke; de Jong, Jeroen; Martorell, Miguel; Letovanec, Igor; Rosell, Rafael; Stahel, Rolf A (2014). Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project. Journal of Clinical Oncology, 32(25):2780-2787.

Peters, Solange; Taron, Miquel; Bubendorf, Lukas; Blackhall, Fiona; Stahel, Rolf (2013). Treatment and detection of ALK-rearranged NSCLC. Lung Cancer, 81(2):145-154.

Lee, James A; Bubendorf, Lukas; Stahel, Rolf; Peters, Solange (2013). Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives. Expert Review of Anticancer Therapy, 13(5):625-36.

Gautschi, Oliver; Dingemans, Anne-Marie; Crowe, Susanne; Peters, Solange; Roder, Heinrich; Grigorieva, Julia; Roder, Joanna; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Baty, Florent; Bubendorf, Lukas; Hsu Schmitz, Shu-Fang; Na, Kyung-Jae; Carbone, David; Stahel, Rolf; Smit, Egbert (2013). VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer, 79(1):59-64.

Buchinger, Katharina

Buchinger, Katharina; Stahel, Rolf; Niggemeier, Verena; Gubler, Christoph; Franzen, Daniel (2013). Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesothelioma. Lung Cancer, 80(3):347-349.

Buchler, Tomas

Stenner, Frank; Chastonay, Rahel; Liewen, Heike; Haile, Sarah R; Cathomas, Richard; Rothermundt, Christian; Siciliano, Raffaele D; Stoll, Susanna; Knuth, Alexander; Buchler, Tomas; Porta, Camillo; Renner, Christoph; Samaras, Panagiotis (2012). A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma. Oncology, 82(6):333-340.

Buckner, Jan

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi;